[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f-sQa36MczmlOaWv7BLptGWWLiNKNqnLZ05TYzEOrmyQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":85,"rows":92},"Hamilton Health Sciences Corporation",[4],244,false,34,46,213471,29,147,[14,17,20,22,25,28,30,32],{"name":15,"count":16},"Asthma",8,{"name":18,"count":19},"Coronary Artery Disease",7,{"name":21,"count":19},"Breast Cancer",{"name":23,"count":24},"Hypertension",6,{"name":26,"count":27},"Bleeding",5,{"name":29,"count":27},"Cardiovascular Disease",{"name":31,"count":27},"Heart Failure",{"name":33,"count":27},"Venous Thromboembolism",[35,40,45,50,55,60,65,70,75,80],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT04452461","Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery","2025-12-12","mFOLFIRINOX",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06622564","Decreasing Postoperative Blood Loss and Seizures by Timing of Intravenous Tranexamic Acid 2 Pilot Trial","2026-01-01","Before CPB Tranexamic Acid",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT05897658","Levetiracetam Prophylaxis in Brain Tumor Resection Pilot","2026-03","Levetiracetam",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06353529","Postop Pain Management in Pituitary Tumour Patients","2026-04","Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT06203977","Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)","2026-05-31","Colchicine",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT07143201","Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT","2026-07","Standard Dose - Ibuprofen oral suspension",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT06908694","Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy","2026-07-31","Semaglutide Pen Injector",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT06836024","A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation","2026-12-30","PEG 3350",{"nctId":76,"briefTitle":77,"date":78,"intervention":79},"NCT06337838","Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","2027-02","Desmopressin Injectable Solution",{"nctId":81,"briefTitle":82,"date":83,"intervention":84},"NCT06174220","Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy","2027-02-01","Tideglusib",[86,87,88,89,90,91],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[93,117,140,158,212,235,261,279,297,315,341,364,389,415,433,451,475,493,519,537,558,585,603,626,650,668,690,708,740,768,802,826,850,878,903,929,956,986,1004,1030,1055,1079,1105,1131,1157,1175,1198,1225,1243,1269,1313,1349,1389,1413,1437,1455,1478,1500,1524,1549,1567,1592,1610,1639,1657,1675,1693,1719,1750,1776,1803,1821,1839,1865,1893,1911,1929,1947,1969,1995,2013,2043,2061,2085,2103,2130,2155,2173,2206,2229,2253,2277,2301,2325,2348,2372,2397,2415,2433,2457,2483,2501,2526,2557,2575,2593,2616,2641,2664,2682,2700,2734,2763,2789,2814,2839,2862,2888,2906,2931,2955,2973,2998,3021,3044,3068,3095],{"intervention":69,"totalTrials":94,"cells":95},1,{"EARLY_PHASE1":96,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":115},{"trials":97,"activeCount":98},[],0,{"trials":100,"activeCount":98},[],{"trials":102,"activeCount":98},[],{"trials":104,"activeCount":98},[],{"trials":106,"activeCount":94,"soonestReadout":68},[107],{"nctId":66,"briefTitle":67,"status":108,"phases":109,"primaryCompletion":68,"completion":68,"start":110,"enrollment":111,"conditions":112,"interventions":114},"RECRUITING",[90],"2025-07-02",20,[113],"Prostate Cancer",[69],{"trials":116,"activeCount":98},[],{"intervention":54,"totalTrials":94,"cells":118},{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":125,"PHASE4":127,"NA":138},{"trials":120,"activeCount":98},[],{"trials":122,"activeCount":98},[],{"trials":124,"activeCount":98},[],{"trials":126,"activeCount":98},[],{"trials":128,"activeCount":94,"soonestReadout":53},[129],{"nctId":51,"briefTitle":52,"status":108,"phases":130,"primaryCompletion":53,"completion":63,"start":131,"enrollment":132,"conditions":133,"interventions":136},[90],"2024-11-25",108,[134,135],"Pituitary","Pain, Postoperative",[54,137],"Sham Comparator",{"trials":139,"activeCount":98},[],{"intervention":137,"totalTrials":94,"cells":141},{"EARLY_PHASE1":142,"PHASE1":144,"PHASE2":146,"PHASE3":148,"PHASE4":150,"NA":156},{"trials":143,"activeCount":98},[],{"trials":145,"activeCount":98},[],{"trials":147,"activeCount":98},[],{"trials":149,"activeCount":98},[],{"trials":151,"activeCount":94,"soonestReadout":53},[152],{"nctId":51,"briefTitle":52,"status":108,"phases":153,"primaryCompletion":53,"completion":63,"start":131,"enrollment":132,"conditions":154,"interventions":155},[90],[134,135],[54,137],{"trials":157,"activeCount":98},[],{"intervention":159,"totalTrials":160,"cells":161},"Vancomycin",3,{"EARLY_PHASE1":162,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":198},{"trials":163,"activeCount":98},[164],{"nctId":165,"briefTitle":166,"status":167,"phases":168,"primaryCompletion":169,"completion":169,"start":170,"enrollment":98,"conditions":171,"interventions":174},"NCT04246151","Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients","WITHDRAWN",[86],"2024-09-12","2022-09-01",[172,173],"Clostridium Difficile Colonization","Clostridium Difficile Diarrhea",[159,175,176],"Vancomycin Placebo","Probiotic Placebo",{"trials":178,"activeCount":98},[],{"trials":180,"activeCount":98},[],{"trials":182,"activeCount":98},[],{"trials":184,"activeCount":94,"soonestReadout":190},[185],{"nctId":186,"briefTitle":187,"status":188,"phases":189,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":194,"interventions":196},"NCT06567808","Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial","NOT_YET_RECRUITING",[90],"2028-04-30","2028-07-30","2026-03-01",38000,[195],"Infection, Surgical Site",[197,159],"Cefazolin",{"trials":199,"activeCount":98},[200],{"nctId":201,"briefTitle":202,"status":203,"phases":204,"primaryCompletion":205,"completion":205,"start":206,"enrollment":207,"conditions":208,"interventions":211},"NCT02285140","Prevention of Infections in Cardiac Surgery","TERMINATED",[91],"2025-03-10","2015-04",5989,[209,210],"Thoracic Surgery","Antibiotic Prophylaxis",[197,159],{"intervention":197,"totalTrials":213,"cells":214},2,{"EARLY_PHASE1":215,"PHASE1":217,"PHASE2":219,"PHASE3":221,"PHASE4":223,"NA":229},{"trials":216,"activeCount":98},[],{"trials":218,"activeCount":98},[],{"trials":220,"activeCount":98},[],{"trials":222,"activeCount":98},[],{"trials":224,"activeCount":94,"soonestReadout":190},[225],{"nctId":186,"briefTitle":187,"status":188,"phases":226,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":227,"interventions":228},[90],[195],[197,159],{"trials":230,"activeCount":98},[231],{"nctId":201,"briefTitle":202,"status":203,"phases":232,"primaryCompletion":205,"completion":205,"start":206,"enrollment":207,"conditions":233,"interventions":234},[91],[209,210],[197,159],{"intervention":44,"totalTrials":94,"cells":236},{"EARLY_PHASE1":237,"PHASE1":239,"PHASE2":241,"PHASE3":243,"PHASE4":257,"NA":259},{"trials":238,"activeCount":98},[],{"trials":240,"activeCount":98},[],{"trials":242,"activeCount":98},[],{"trials":244,"activeCount":94,"soonestReadout":43},[245],{"nctId":41,"briefTitle":42,"status":188,"phases":246,"primaryCompletion":43,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":253},[89],"2026-02-01","2025-01-01",40,[26,251,252],"Surgical Blood Loss","Seizures",[44,254,255,256],"After CPB Tranexamic Acid","Before CPB Placebo","After CPB Placebo",{"trials":258,"activeCount":98},[],{"trials":260,"activeCount":98},[],{"intervention":254,"totalTrials":94,"cells":262},{"EARLY_PHASE1":263,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":275,"NA":277},{"trials":264,"activeCount":98},[],{"trials":266,"activeCount":98},[],{"trials":268,"activeCount":98},[],{"trials":270,"activeCount":94,"soonestReadout":43},[271],{"nctId":41,"briefTitle":42,"status":188,"phases":272,"primaryCompletion":43,"completion":247,"start":248,"enrollment":249,"conditions":273,"interventions":274},[89],[26,251,252],[44,254,255,256],{"trials":276,"activeCount":98},[],{"trials":278,"activeCount":98},[],{"intervention":255,"totalTrials":94,"cells":280},{"EARLY_PHASE1":281,"PHASE1":283,"PHASE2":285,"PHASE3":287,"PHASE4":293,"NA":295},{"trials":282,"activeCount":98},[],{"trials":284,"activeCount":98},[],{"trials":286,"activeCount":98},[],{"trials":288,"activeCount":94,"soonestReadout":43},[289],{"nctId":41,"briefTitle":42,"status":188,"phases":290,"primaryCompletion":43,"completion":247,"start":248,"enrollment":249,"conditions":291,"interventions":292},[89],[26,251,252],[44,254,255,256],{"trials":294,"activeCount":98},[],{"trials":296,"activeCount":98},[],{"intervention":256,"totalTrials":94,"cells":298},{"EARLY_PHASE1":299,"PHASE1":301,"PHASE2":303,"PHASE3":305,"PHASE4":311,"NA":313},{"trials":300,"activeCount":98},[],{"trials":302,"activeCount":98},[],{"trials":304,"activeCount":98},[],{"trials":306,"activeCount":94,"soonestReadout":43},[307],{"nctId":41,"briefTitle":42,"status":188,"phases":308,"primaryCompletion":43,"completion":247,"start":248,"enrollment":249,"conditions":309,"interventions":310},[89],[26,251,252],[44,254,255,256],{"trials":312,"activeCount":98},[],{"trials":314,"activeCount":98},[],{"intervention":316,"totalTrials":94,"cells":317},"Chemotherapy\u002FRadiation",{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":322,"PHASE3":324,"PHASE4":337,"NA":339},{"trials":319,"activeCount":98},[],{"trials":321,"activeCount":98},[],{"trials":323,"activeCount":98},[],{"trials":325,"activeCount":94,"soonestReadout":330},[326],{"nctId":327,"briefTitle":328,"status":188,"phases":329,"primaryCompletion":330,"completion":331,"start":332,"enrollment":333,"conditions":334,"interventions":336},"NCT07027436","Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.",[89],"2027-10-12","2028-10-10","2025-07-07",30,[335],"Hepatocellular Carcinoma (HCC)",[316],{"trials":338,"activeCount":98},[],{"trials":340,"activeCount":98},[],{"intervention":74,"totalTrials":94,"cells":342},{"EARLY_PHASE1":343,"PHASE1":345,"PHASE2":347,"PHASE3":349,"PHASE4":360,"NA":362},{"trials":344,"activeCount":98},[],{"trials":346,"activeCount":98},[],{"trials":348,"activeCount":98},[],{"trials":350,"activeCount":94,"soonestReadout":73},[351],{"nctId":71,"briefTitle":72,"status":188,"phases":352,"primaryCompletion":73,"completion":83,"start":353,"enrollment":354,"conditions":355,"interventions":359},[88,89],"2025-06-01",60,[356,357,358],"Constipation - Functional","Constipation","Constipation Aggravated",[74],{"trials":361,"activeCount":98},[],{"trials":363,"activeCount":98},[],{"intervention":365,"totalTrials":94,"cells":366},"Extra 600mg of Rifampicin",{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":373,"PHASE4":385,"NA":387},{"trials":368,"activeCount":98},[],{"trials":370,"activeCount":98},[],{"trials":372,"activeCount":98},[],{"trials":374,"activeCount":94,"soonestReadout":379},[375],{"nctId":376,"briefTitle":377,"status":188,"phases":378,"primaryCompletion":379,"completion":380,"start":247,"enrollment":381,"conditions":382,"interventions":384},"NCT07118696","Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease",[89],"2029-01-31","2030-01-31",1000,[383],"Pulmonary TB",[365],{"trials":386,"activeCount":98},[],{"trials":388,"activeCount":98},[],{"intervention":390,"totalTrials":94,"cells":391},"Colchicine 0.5 MG",{"EARLY_PHASE1":392,"PHASE1":394,"PHASE2":396,"PHASE3":398,"PHASE4":411,"NA":413},{"trials":393,"activeCount":98},[],{"trials":395,"activeCount":98},[],{"trials":397,"activeCount":98},[],{"trials":399,"activeCount":94,"soonestReadout":404},[400],{"nctId":401,"briefTitle":402,"status":108,"phases":403,"primaryCompletion":404,"completion":404,"start":405,"enrollment":406,"conditions":407,"interventions":408},"NCT05873881","COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease",[89],"2027-06","2024-01-29",2500,[31],[390,409,410],"Colchicine placebo","Thiamine Mononitrate 300 mg",{"trials":412,"activeCount":98},[],{"trials":414,"activeCount":98},[],{"intervention":409,"totalTrials":94,"cells":416},{"EARLY_PHASE1":417,"PHASE1":419,"PHASE2":421,"PHASE3":423,"PHASE4":429,"NA":431},{"trials":418,"activeCount":98},[],{"trials":420,"activeCount":98},[],{"trials":422,"activeCount":98},[],{"trials":424,"activeCount":94,"soonestReadout":404},[425],{"nctId":401,"briefTitle":402,"status":108,"phases":426,"primaryCompletion":404,"completion":404,"start":405,"enrollment":406,"conditions":427,"interventions":428},[89],[31],[390,409,410],{"trials":430,"activeCount":98},[],{"trials":432,"activeCount":98},[],{"intervention":410,"totalTrials":94,"cells":434},{"EARLY_PHASE1":435,"PHASE1":437,"PHASE2":439,"PHASE3":441,"PHASE4":447,"NA":449},{"trials":436,"activeCount":98},[],{"trials":438,"activeCount":98},[],{"trials":440,"activeCount":98},[],{"trials":442,"activeCount":94,"soonestReadout":404},[443],{"nctId":401,"briefTitle":402,"status":108,"phases":444,"primaryCompletion":404,"completion":404,"start":405,"enrollment":406,"conditions":445,"interventions":446},[89],[31],[390,409,410],{"trials":448,"activeCount":98},[],{"trials":450,"activeCount":98},[],{"intervention":79,"totalTrials":94,"cells":452},{"EARLY_PHASE1":453,"PHASE1":455,"PHASE2":457,"PHASE3":459,"PHASE4":471,"NA":473},{"trials":454,"activeCount":98},[],{"trials":456,"activeCount":98},[],{"trials":458,"activeCount":98},[],{"trials":460,"activeCount":94,"soonestReadout":78},[461],{"nctId":76,"briefTitle":77,"status":108,"phases":462,"primaryCompletion":78,"completion":404,"start":463,"enrollment":464,"conditions":465,"interventions":469},[89],"2025-06-09",100,[466,467,26,468],"Chronic Kidney Diseases","Acute Kidney Injury","Surgery",[79,470],"Tranexamic Acid Injectable Product",{"trials":472,"activeCount":98},[],{"trials":474,"activeCount":98},[],{"intervention":470,"totalTrials":94,"cells":476},{"EARLY_PHASE1":477,"PHASE1":479,"PHASE2":481,"PHASE3":483,"PHASE4":489,"NA":491},{"trials":478,"activeCount":98},[],{"trials":480,"activeCount":98},[],{"trials":482,"activeCount":98},[],{"trials":484,"activeCount":94,"soonestReadout":78},[485],{"nctId":76,"briefTitle":77,"status":108,"phases":486,"primaryCompletion":78,"completion":404,"start":463,"enrollment":464,"conditions":487,"interventions":488},[89],[466,467,26,468],[79,470],{"trials":490,"activeCount":98},[],{"trials":492,"activeCount":98},[],{"intervention":494,"totalTrials":94,"cells":495},"Chlorhexidine Gluconate",{"EARLY_PHASE1":496,"PHASE1":498,"PHASE2":500,"PHASE3":502,"PHASE4":515,"NA":517},{"trials":497,"activeCount":98},[],{"trials":499,"activeCount":98},[],{"trials":501,"activeCount":98},[],{"trials":503,"activeCount":94,"soonestReadout":508},[504],{"nctId":505,"briefTitle":506,"status":108,"phases":507,"primaryCompletion":508,"completion":508,"start":509,"enrollment":510,"conditions":511,"interventions":513},"NCT06126614","Infection Prophylaxis in Total Joint Replacement",[89],"2028-11","2024-05-07",21006,[512],"Periprosthetic Joint Infection",[494,514],"Vancomycin Hydrochloride",{"trials":516,"activeCount":98},[],{"trials":518,"activeCount":98},[],{"intervention":514,"totalTrials":94,"cells":520},{"EARLY_PHASE1":521,"PHASE1":523,"PHASE2":525,"PHASE3":527,"PHASE4":533,"NA":535},{"trials":522,"activeCount":98},[],{"trials":524,"activeCount":98},[],{"trials":526,"activeCount":98},[],{"trials":528,"activeCount":94,"soonestReadout":508},[529],{"nctId":505,"briefTitle":506,"status":108,"phases":530,"primaryCompletion":508,"completion":508,"start":509,"enrollment":510,"conditions":531,"interventions":532},[89],[512],[494,514],{"trials":534,"activeCount":98},[],{"trials":536,"activeCount":98},[],{"intervention":49,"totalTrials":94,"cells":538},{"EARLY_PHASE1":539,"PHASE1":541,"PHASE2":543,"PHASE3":545,"PHASE4":554,"NA":556},{"trials":540,"activeCount":98},[],{"trials":542,"activeCount":98},[],{"trials":544,"activeCount":98},[],{"trials":546,"activeCount":94,"soonestReadout":48},[547],{"nctId":46,"briefTitle":47,"status":188,"phases":548,"primaryCompletion":48,"completion":48,"start":549,"enrollment":550,"conditions":551,"interventions":553},[89],"2025-03",70,[252,552],"Brain Tumor",[49],{"trials":555,"activeCount":98},[],{"trials":557,"activeCount":98},[],{"intervention":559,"totalTrials":94,"cells":560},"Metformin",{"EARLY_PHASE1":561,"PHASE1":563,"PHASE2":565,"PHASE3":579,"PHASE4":581,"NA":583},{"trials":562,"activeCount":98},[],{"trials":564,"activeCount":98},[],{"trials":566,"activeCount":94,"soonestReadout":571},[567],{"nctId":568,"briefTitle":569,"status":188,"phases":570,"primaryCompletion":571,"completion":572,"start":573,"enrollment":574,"conditions":575,"interventions":577},"NCT04530058","The Effects of Metformin on Morbidity and Mortality in Elderly Patients",[88],"2028-03","2029-03","2024-11",250,[576],"Burns",[559,578],"Placebos",{"trials":580,"activeCount":98},[],{"trials":582,"activeCount":98},[],{"trials":584,"activeCount":98},[],{"intervention":578,"totalTrials":94,"cells":586},{"EARLY_PHASE1":587,"PHASE1":589,"PHASE2":591,"PHASE3":597,"PHASE4":599,"NA":601},{"trials":588,"activeCount":98},[],{"trials":590,"activeCount":98},[],{"trials":592,"activeCount":94,"soonestReadout":571},[593],{"nctId":568,"briefTitle":569,"status":188,"phases":594,"primaryCompletion":571,"completion":572,"start":573,"enrollment":574,"conditions":595,"interventions":596},[88],[576],[559,578],{"trials":598,"activeCount":98},[],{"trials":600,"activeCount":98},[],{"trials":602,"activeCount":98},[],{"intervention":84,"totalTrials":94,"cells":604},{"EARLY_PHASE1":605,"PHASE1":607,"PHASE2":609,"PHASE3":620,"PHASE4":622,"NA":624},{"trials":606,"activeCount":98},[],{"trials":608,"activeCount":98},[],{"trials":610,"activeCount":94,"soonestReadout":83},[611],{"nctId":81,"briefTitle":82,"status":108,"phases":612,"primaryCompletion":83,"completion":613,"start":614,"enrollment":615,"conditions":616,"interventions":619},[88],"2027-07-01","2025-03-21",120,[617,618],"Arrhythmogenic Cardiomyopathy","Arrhythmogenic Right Ventricular Cardiomyopathy",[84],{"trials":621,"activeCount":98},[],{"trials":623,"activeCount":98},[],{"trials":625,"activeCount":98},[],{"intervention":64,"totalTrials":94,"cells":627},{"EARLY_PHASE1":628,"PHASE1":630,"PHASE2":632,"PHASE3":644,"PHASE4":646,"NA":648},{"trials":629,"activeCount":98},[],{"trials":631,"activeCount":98},[],{"trials":633,"activeCount":94,"soonestReadout":63},[634],{"nctId":61,"briefTitle":62,"status":108,"phases":635,"primaryCompletion":63,"completion":636,"start":637,"enrollment":638,"conditions":639,"interventions":642},[88],"2027-07","2024-07-04",26,[640,641],"Patent Ductus Arteriosus","Preterm",[64,643],"Precision Dose - Ibuprofen oral suspension",{"trials":645,"activeCount":98},[],{"trials":647,"activeCount":98},[],{"trials":649,"activeCount":98},[],{"intervention":643,"totalTrials":94,"cells":651},{"EARLY_PHASE1":652,"PHASE1":654,"PHASE2":656,"PHASE3":662,"PHASE4":664,"NA":666},{"trials":653,"activeCount":98},[],{"trials":655,"activeCount":98},[],{"trials":657,"activeCount":94,"soonestReadout":63},[658],{"nctId":61,"briefTitle":62,"status":108,"phases":659,"primaryCompletion":63,"completion":636,"start":637,"enrollment":638,"conditions":660,"interventions":661},[88],[640,641],[64,643],{"trials":663,"activeCount":98},[],{"trials":665,"activeCount":98},[],{"trials":667,"activeCount":98},[],{"intervention":39,"totalTrials":94,"cells":669},{"EARLY_PHASE1":670,"PHASE1":672,"PHASE2":674,"PHASE3":684,"PHASE4":686,"NA":688},{"trials":671,"activeCount":98},[],{"trials":673,"activeCount":98},[],{"trials":675,"activeCount":94,"soonestReadout":38},[676],{"nctId":36,"briefTitle":37,"status":108,"phases":677,"primaryCompletion":38,"completion":678,"start":679,"enrollment":333,"conditions":680,"interventions":682},[88],"2026-05-01","2021-03-01",[681],"Pancreatic Adenocarcinoma",[39,683],"Gemcitabine \u002F Nab-paclitaxel",{"trials":685,"activeCount":98},[],{"trials":687,"activeCount":98},[],{"trials":689,"activeCount":98},[],{"intervention":683,"totalTrials":94,"cells":691},{"EARLY_PHASE1":692,"PHASE1":694,"PHASE2":696,"PHASE3":702,"PHASE4":704,"NA":706},{"trials":693,"activeCount":98},[],{"trials":695,"activeCount":98},[],{"trials":697,"activeCount":94,"soonestReadout":38},[698],{"nctId":36,"briefTitle":37,"status":108,"phases":699,"primaryCompletion":38,"completion":678,"start":679,"enrollment":333,"conditions":700,"interventions":701},[88],[681],[39,683],{"trials":703,"activeCount":98},[],{"trials":705,"activeCount":98},[],{"trials":707,"activeCount":98},[],{"intervention":59,"totalTrials":213,"cells":709},{"EARLY_PHASE1":710,"PHASE1":712,"PHASE2":721,"PHASE3":723,"PHASE4":736,"NA":738},{"trials":711,"activeCount":98},[],{"trials":713,"activeCount":94,"soonestReadout":58},[714],{"nctId":56,"briefTitle":57,"status":108,"phases":715,"primaryCompletion":58,"completion":58,"start":716,"enrollment":717,"conditions":718,"interventions":720},[87],"2024-11-15",200,[466,719],"Renal Failure",[59],{"trials":722,"activeCount":98},[],{"trials":724,"activeCount":98},[725],{"nctId":726,"briefTitle":727,"status":728,"phases":729,"primaryCompletion":730,"completion":730,"start":731,"enrollment":732,"conditions":733,"interventions":735},"NCT00754819","Targeting Inflammation in Acute Coronary Syndrome Using Colchicine","COMPLETED",[88,89],"2009-09","2008-04",80,[734],"Acute Coronary Syndrome",[59],{"trials":737,"activeCount":98},[],{"trials":739,"activeCount":98},[],{"intervention":741,"totalTrials":94,"cells":742},"Fecal Microbiota Transplant",{"EARLY_PHASE1":743,"PHASE1":745,"PHASE2":747,"PHASE3":749,"PHASE4":751,"NA":753},{"trials":744,"activeCount":98},[],{"trials":746,"activeCount":98},[],{"trials":748,"activeCount":98},[],{"trials":750,"activeCount":98},[],{"trials":752,"activeCount":98},[],{"trials":754,"activeCount":94,"soonestReadout":759},[755],{"nctId":756,"briefTitle":757,"status":188,"phases":758,"primaryCompletion":759,"completion":759,"start":760,"enrollment":111,"conditions":761,"interventions":767},"NCT06593366","Fecal Microbiota Transplant for Anorexia Nervosa",[91],"2027-06-01","2026-06-01",[762,763,764,765,766],"Anorexia Nervosa Restricting Type","Anorexia Nervosa","Anorexia in Adolescence","Anorexia in Children","Anorexia",[741],{"intervention":769,"totalTrials":213,"cells":770},"Enoxaparin",{"EARLY_PHASE1":771,"PHASE1":773,"PHASE2":775,"PHASE3":777,"PHASE4":788,"NA":800},{"trials":772,"activeCount":98},[],{"trials":774,"activeCount":98},[],{"trials":776,"activeCount":98},[],{"trials":778,"activeCount":98},[779],{"nctId":780,"briefTitle":781,"status":782,"phases":783,"primaryCompletion":784,"completion":784,"start":785,"enrollment":111,"conditions":786,"interventions":787},"NCT02486666","Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose","UNKNOWN",[89],"2022-12","2016-03",[33],[769],{"trials":789,"activeCount":98},[790],{"nctId":791,"briefTitle":792,"status":728,"phases":793,"completion":794,"start":795,"enrollment":464,"conditions":796,"interventions":798},"NCT00253396","Patients Preference With Self-Injection: The PRISM Study",[90],"2007-01","2005-10",[797],"Bruises",[799,769],"Unfractionated heparin",{"trials":801,"activeCount":98},[],{"intervention":803,"totalTrials":94,"cells":804},"Olanzapine & Quetiapine",{"EARLY_PHASE1":805,"PHASE1":807,"PHASE2":809,"PHASE3":811,"PHASE4":813,"NA":824},{"trials":806,"activeCount":98},[],{"trials":808,"activeCount":98},[],{"trials":810,"activeCount":98},[],{"trials":812,"activeCount":98},[],{"trials":814,"activeCount":98},[815],{"nctId":816,"briefTitle":817,"status":728,"phases":818,"completion":819,"start":820,"enrollment":732,"conditions":821,"interventions":823},"NCT00182442","Cognition, Functioning and Quality of Life",[90],"2006-03","2003-10",[822],"Schizophrenia",[803],{"trials":825,"activeCount":98},[],{"intervention":827,"totalTrials":94,"cells":828},"Vitamins: Folic acid, B6, B12",{"EARLY_PHASE1":829,"PHASE1":831,"PHASE2":833,"PHASE3":835,"PHASE4":837,"NA":848},{"trials":830,"activeCount":98},[],{"trials":832,"activeCount":98},[],{"trials":834,"activeCount":98},[],{"trials":836,"activeCount":98},[],{"trials":838,"activeCount":98},[839],{"nctId":840,"briefTitle":841,"status":782,"phases":842,"completion":795,"start":843,"enrollment":844,"conditions":845,"interventions":847},"NCT00217178","Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)",[90],"2000-01",900,[846,29],"Atherosclerosis",[827],{"trials":849,"activeCount":98},[],{"intervention":851,"totalTrials":94,"cells":852},"clonidine",{"EARLY_PHASE1":853,"PHASE1":855,"PHASE2":857,"PHASE3":859,"PHASE4":861,"NA":876},{"trials":854,"activeCount":98},[],{"trials":856,"activeCount":98},[],{"trials":858,"activeCount":98},[],{"trials":860,"activeCount":98},[],{"trials":862,"activeCount":98},[863],{"nctId":864,"briefTitle":865,"status":728,"phases":866,"primaryCompletion":867,"completion":867,"start":868,"enrollment":869,"conditions":870,"interventions":875},"NCT00959062","Adjunctive Clonidine in the Sedation of Mechanically Ventilated Children",[90],"2012-09","2010-01",50,[871,872,873,874],"Respiration, Artificial","Critical Illness","Conscious Sedation","Deep Sedation",[851],{"trials":877,"activeCount":98},[],{"intervention":879,"totalTrials":94,"cells":880},"Lansoprazole",{"EARLY_PHASE1":881,"PHASE1":883,"PHASE2":885,"PHASE3":887,"PHASE4":889,"NA":901},{"trials":882,"activeCount":98},[],{"trials":884,"activeCount":98},[],{"trials":886,"activeCount":98},[],{"trials":888,"activeCount":98},[],{"trials":890,"activeCount":98},[891],{"nctId":892,"briefTitle":893,"status":728,"phases":894,"primaryCompletion":895,"completion":895,"start":896,"enrollment":897,"conditions":898,"interventions":900},"NCT01082029","Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children",[90],"2014-06","2010-03",65,[899],"Otitis Media With Effusion",[879],{"trials":902,"activeCount":98},[],{"intervention":904,"totalTrials":94,"cells":905},"Warfarin vs ASA",{"EARLY_PHASE1":906,"PHASE1":908,"PHASE2":910,"PHASE3":912,"PHASE4":914,"NA":927},{"trials":907,"activeCount":98},[],{"trials":909,"activeCount":98},[],{"trials":911,"activeCount":98},[],{"trials":913,"activeCount":98},[],{"trials":915,"activeCount":98},[916],{"nctId":917,"briefTitle":918,"status":728,"phases":919,"completion":920,"start":921,"enrollment":922,"conditions":923,"interventions":926},"NCT00182104","International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures",[90],"2005-07","1998-08",111,[924,925],"Heart Defect","Triscupid Atresia",[904],{"trials":928,"activeCount":98},[],{"intervention":930,"totalTrials":94,"cells":931},"optimizing therapeutic treatments",{"EARLY_PHASE1":932,"PHASE1":934,"PHASE2":936,"PHASE3":938,"PHASE4":940,"NA":954},{"trials":933,"activeCount":98},[],{"trials":935,"activeCount":98},[],{"trials":937,"activeCount":98},[],{"trials":939,"activeCount":98},[],{"trials":941,"activeCount":98},[942],{"nctId":943,"briefTitle":944,"status":728,"phases":945,"completion":946,"start":947,"enrollment":948,"conditions":949,"interventions":953},"NCT00157638","Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics",[90],"2006-07","2004-02",1400,[950,23,951,357,952],"Diabetes","Hyperlipidemia","Pain",[930],{"trials":955,"activeCount":98},[],{"intervention":957,"totalTrials":94,"cells":958},"Sertraline",{"EARLY_PHASE1":959,"PHASE1":961,"PHASE2":963,"PHASE3":965,"PHASE4":967,"NA":984},{"trials":960,"activeCount":98},[],{"trials":962,"activeCount":98},[],{"trials":964,"activeCount":98},[],{"trials":966,"activeCount":98},[],{"trials":968,"activeCount":98},[969],{"nctId":970,"briefTitle":971,"status":203,"phases":972,"primaryCompletion":973,"completion":973,"start":974,"enrollment":975,"conditions":976,"interventions":983},"NCT00182533","Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders",[90],"2018-01","2002-07",170,[977,978,979,980,981,982],"Phobia, Social","Panic Disorder","Agoraphobia","Obsessive-Compulsive Disorder","Anxiety Disorders","Major Depressive Disorder",[957],{"trials":985,"activeCount":98},[],{"intervention":799,"totalTrials":94,"cells":987},{"EARLY_PHASE1":988,"PHASE1":990,"PHASE2":992,"PHASE3":994,"PHASE4":996,"NA":1002},{"trials":989,"activeCount":98},[],{"trials":991,"activeCount":98},[],{"trials":993,"activeCount":98},[],{"trials":995,"activeCount":98},[],{"trials":997,"activeCount":98},[998],{"nctId":791,"briefTitle":792,"status":728,"phases":999,"completion":794,"start":795,"enrollment":464,"conditions":1000,"interventions":1001},[90],[797],[799,769],{"trials":1003,"activeCount":98},[],{"intervention":1005,"totalTrials":94,"cells":1006},"Tissue Plasminogen Activator",{"EARLY_PHASE1":1007,"PHASE1":1009,"PHASE2":1011,"PHASE3":1013,"PHASE4":1015,"NA":1028},{"trials":1008,"activeCount":98},[],{"trials":1010,"activeCount":98},[],{"trials":1012,"activeCount":98},[],{"trials":1014,"activeCount":98},[],{"trials":1016,"activeCount":98},[1017],{"nctId":1018,"briefTitle":1019,"status":728,"phases":1020,"primaryCompletion":1021,"completion":1022,"start":1023,"enrollment":249,"conditions":1024,"interventions":1027},"NCT05491356","Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas",[90],"2024-03-30","2024-05-30","2023-05-11",[1025,1026],"Hematoma, Subdural","Fibrinolytic; Hemorrhage",[1005],{"trials":1029,"activeCount":98},[],{"intervention":1031,"totalTrials":94,"cells":1032},"naproxen",{"EARLY_PHASE1":1033,"PHASE1":1035,"PHASE2":1037,"PHASE3":1039,"PHASE4":1041,"NA":1053},{"trials":1034,"activeCount":98},[],{"trials":1036,"activeCount":98},[],{"trials":1038,"activeCount":98},[],{"trials":1040,"activeCount":98},[],{"trials":1042,"activeCount":98},[1043],{"nctId":1044,"briefTitle":1045,"status":782,"phases":1046,"primaryCompletion":1047,"completion":1048,"start":1049,"enrollment":1050,"conditions":1051,"interventions":1052},"NCT00615875","Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial",[90],"2008-05","2008-06","2008-03",24,[135],[1031],{"trials":1054,"activeCount":98},[],{"intervention":1056,"totalTrials":94,"cells":1057},"Duloxetine",{"EARLY_PHASE1":1058,"PHASE1":1060,"PHASE2":1062,"PHASE3":1064,"PHASE4":1066,"NA":1077},{"trials":1059,"activeCount":98},[],{"trials":1061,"activeCount":98},[],{"trials":1063,"activeCount":98},[],{"trials":1065,"activeCount":98},[],{"trials":1067,"activeCount":98},[1068],{"nctId":1069,"briefTitle":1070,"status":782,"phases":1071,"primaryCompletion":1072,"completion":1073,"start":1074,"enrollment":550,"conditions":1075,"interventions":1076},"NCT00889369","Duloxetine for Major Depression in Peri-\u002FPostmenopausal Women",[90],"2012-02","2012-06","2009-05",[982],[1056],{"trials":1078,"activeCount":98},[],{"intervention":1080,"totalTrials":94,"cells":1081},"Amoxicillin",{"EARLY_PHASE1":1082,"PHASE1":1084,"PHASE2":1086,"PHASE3":1088,"PHASE4":1090,"NA":1103},{"trials":1083,"activeCount":98},[],{"trials":1085,"activeCount":98},[],{"trials":1087,"activeCount":98},[],{"trials":1089,"activeCount":98},[],{"trials":1091,"activeCount":98},[1092],{"nctId":1093,"briefTitle":1094,"status":728,"phases":1095,"primaryCompletion":1096,"completion":1097,"start":1098,"enrollment":1099,"conditions":1100,"interventions":1102},"NCT02380352","Short-course Antimicrobial Therapy for Paediatric Respiratory Infections",[90],"2019-12","2020-04","2016-09",281,[1101],"Community-acquired Pneumonia",[1080],{"trials":1104,"activeCount":98},[],{"intervention":210,"totalTrials":94,"cells":1106},{"EARLY_PHASE1":1107,"PHASE1":1109,"PHASE2":1111,"PHASE3":1113,"PHASE4":1115,"NA":1129},{"trials":1108,"activeCount":98},[],{"trials":1110,"activeCount":98},[],{"trials":1112,"activeCount":98},[],{"trials":1114,"activeCount":98},[],{"trials":1116,"activeCount":98},[1117],{"nctId":1118,"briefTitle":1119,"status":782,"phases":1120,"primaryCompletion":1121,"completion":1122,"start":1123,"enrollment":1124,"conditions":1125,"interventions":1128},"NCT05438082","Antibiotic Prophylaxis to Prevent Post-procedure UTI After VCUG",[90],"2024-10","2024-12","2023-10",84,[210,1126,1127],"Voiding Cystourethrogram","Febrile Urinary Tract Infection",[210],{"trials":1130,"activeCount":98},[],{"intervention":1132,"totalTrials":94,"cells":1133},"Fluticasone propionate (Flovent Diskus) 250 mcg",{"EARLY_PHASE1":1134,"PHASE1":1136,"PHASE2":1138,"PHASE3":1140,"PHASE4":1142,"NA":1155},{"trials":1135,"activeCount":98},[],{"trials":1137,"activeCount":98},[],{"trials":1139,"activeCount":98},[],{"trials":1141,"activeCount":98},[],{"trials":1143,"activeCount":98},[1144],{"nctId":1145,"briefTitle":1146,"status":728,"phases":1147,"primaryCompletion":1148,"completion":1149,"start":1150,"enrollment":19,"conditions":1151,"interventions":1153},"NCT00716963","Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?",[90],"2008-11","2008-12","2008-07",[1152],"Mild Intermittent Asthma",[1132,1154],"budesonide 400 mcg",{"trials":1156,"activeCount":98},[],{"intervention":1154,"totalTrials":94,"cells":1158},{"EARLY_PHASE1":1159,"PHASE1":1161,"PHASE2":1163,"PHASE3":1165,"PHASE4":1167,"NA":1173},{"trials":1160,"activeCount":98},[],{"trials":1162,"activeCount":98},[],{"trials":1164,"activeCount":98},[],{"trials":1166,"activeCount":98},[],{"trials":1168,"activeCount":98},[1169],{"nctId":1145,"briefTitle":1146,"status":728,"phases":1170,"primaryCompletion":1148,"completion":1149,"start":1150,"enrollment":19,"conditions":1171,"interventions":1172},[90],[1152],[1132,1154],{"trials":1174,"activeCount":98},[],{"intervention":1176,"totalTrials":94,"cells":1177},"Olanzapine",{"EARLY_PHASE1":1178,"PHASE1":1180,"PHASE2":1182,"PHASE3":1184,"PHASE4":1186,"NA":1196},{"trials":1179,"activeCount":98},[],{"trials":1181,"activeCount":98},[],{"trials":1183,"activeCount":98},[],{"trials":1185,"activeCount":98},[],{"trials":1187,"activeCount":98},[1188],{"nctId":1189,"briefTitle":1190,"status":728,"phases":1191,"completion":819,"start":1192,"enrollment":8,"conditions":1193,"interventions":1195},"NCT00182507","Olanzapine in the Treatment of Hair Pulling (Trichotillomania)",[90],"2000-06",[1194],"Trichotillomania",[1176],{"trials":1197,"activeCount":98},[],{"intervention":1199,"totalTrials":94,"cells":1200},"Tranexamic Acid 100mg\u002FmL, 20mL topical",{"EARLY_PHASE1":1201,"PHASE1":1203,"PHASE2":1205,"PHASE3":1207,"PHASE4":1209,"NA":1223},{"trials":1202,"activeCount":98},[],{"trials":1204,"activeCount":98},[],{"trials":1206,"activeCount":98},[],{"trials":1208,"activeCount":98},[],{"trials":1210,"activeCount":98},[1211],{"nctId":1212,"briefTitle":1213,"status":782,"phases":1214,"primaryCompletion":1215,"completion":1216,"start":1217,"enrollment":464,"conditions":1218,"interventions":1221},"NCT03738527","SEroma Reduction pOst MAstectomy \"SEROMA Study\"",[90],"2022-01","2022-07","2019-10-07",[1219,1220,21],"Seroma Complicating A Procedure","Hematoma Postoperative",[1199,1222],"Normal Saline Flush, 0.9%, 20mL topical",{"trials":1224,"activeCount":98},[],{"intervention":1222,"totalTrials":94,"cells":1226},{"EARLY_PHASE1":1227,"PHASE1":1229,"PHASE2":1231,"PHASE3":1233,"PHASE4":1235,"NA":1241},{"trials":1228,"activeCount":98},[],{"trials":1230,"activeCount":98},[],{"trials":1232,"activeCount":98},[],{"trials":1234,"activeCount":98},[],{"trials":1236,"activeCount":98},[1237],{"nctId":1212,"briefTitle":1213,"status":782,"phases":1238,"primaryCompletion":1215,"completion":1216,"start":1217,"enrollment":464,"conditions":1239,"interventions":1240},[90],[1219,1220,21],[1199,1222],{"trials":1242,"activeCount":98},[],{"intervention":1244,"totalTrials":94,"cells":1245},"Folic acid, vitamin B6 and B12 or placebo",{"EARLY_PHASE1":1246,"PHASE1":1248,"PHASE2":1250,"PHASE3":1252,"PHASE4":1254,"NA":1267},{"trials":1247,"activeCount":98},[],{"trials":1249,"activeCount":98},[],{"trials":1251,"activeCount":98},[],{"trials":1253,"activeCount":98},[],{"trials":1255,"activeCount":98},[1256],{"nctId":1257,"briefTitle":1258,"status":782,"phases":1259,"completion":795,"start":1260,"enrollment":1261,"conditions":1262,"interventions":1266},"NCT00106886","HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)",[90],"1999-12",5000,[29,1263,1264,1265],"Myocardial Infarction","Stroke","Cancer",[1244],{"trials":1268,"activeCount":98},[],{"intervention":1270,"totalTrials":160,"cells":1271},"Aspirin",{"EARLY_PHASE1":1272,"PHASE1":1274,"PHASE2":1276,"PHASE3":1298,"PHASE4":1309,"NA":1311},{"trials":1273,"activeCount":98},[],{"trials":1275,"activeCount":98},[],{"trials":1277,"activeCount":98},[1278,1288],{"nctId":1279,"briefTitle":1280,"status":728,"phases":1281,"primaryCompletion":1282,"completion":1283,"start":1284,"enrollment":615,"conditions":1285,"interventions":1287},"NCT01618006","Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery",[88],"2013-04","2013-08","2012-01",[1286],"Postoperative; Dysfunction Following Cardiac Surgery",[1270,1270,1270],{"nctId":1289,"briefTitle":1290,"status":728,"phases":1291,"primaryCompletion":1292,"completion":1293,"start":1294,"enrollment":550,"conditions":1295,"interventions":1297},"NCT01902498","Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B",[88],"2014-03","2014-07","2013-07",[1296],"Postoperative Dysfunction Following Cardiac Surgery",[1270,1270,1270],{"trials":1299,"activeCount":98},[1300],{"nctId":1301,"briefTitle":1302,"status":728,"phases":1303,"primaryCompletion":1048,"completion":1149,"start":946,"enrollment":1304,"conditions":1305,"interventions":1307},"NCT00330772","Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study",[89],150,[18,1306],"Coronary Artery Bypass Grafting",[1270,1308],"Clopidogrel",{"trials":1310,"activeCount":98},[],{"trials":1312,"activeCount":98},[],{"intervention":1314,"totalTrials":213,"cells":1315},"warfarin",{"EARLY_PHASE1":1316,"PHASE1":1318,"PHASE2":1320,"PHASE3":1333,"PHASE4":1345,"NA":1347},{"trials":1317,"activeCount":98},[],{"trials":1319,"activeCount":98},[],{"trials":1321,"activeCount":98},[1322],{"nctId":1323,"briefTitle":1324,"status":728,"phases":1325,"primaryCompletion":1326,"completion":1327,"start":946,"enrollment":1328,"conditions":1329,"interventions":1332},"NCT00814177","Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients",[88],"2009-01","2009-04",160,[1330,33,1331,1263],"Atrial Fibrillation","Ischemic Stroke",[1314,1314],{"trials":1334,"activeCount":98},[1335],{"nctId":1336,"briefTitle":1337,"status":728,"phases":1338,"primaryCompletion":1339,"completion":1339,"start":1340,"enrollment":975,"conditions":1341,"interventions":1344},"NCT00157651","Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters",[89],"2007-03","1999-02",[1342,1343,26],"End Stage Renal Disease","Thrombosis",[1314],{"trials":1346,"activeCount":98},[],{"trials":1348,"activeCount":98},[],{"intervention":1350,"totalTrials":213,"cells":1351},"Doxycycline",{"EARLY_PHASE1":1352,"PHASE1":1354,"PHASE2":1356,"PHASE3":1371,"PHASE4":1385,"NA":1387},{"trials":1353,"activeCount":98},[],{"trials":1355,"activeCount":98},[],{"trials":1357,"activeCount":98},[1358],{"nctId":1359,"briefTitle":1360,"status":728,"phases":1361,"primaryCompletion":1362,"completion":1363,"start":1364,"enrollment":1365,"conditions":1366,"interventions":1368},"NCT02606032","Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis",[88],"2021-01","2021-01-27","2016-05",75,[1367],"Ulcerative Colitis",[1369,1350,1370],"Metronidazole","Terbinafine",{"trials":1372,"activeCount":98},[1373],{"nctId":1374,"briefTitle":1375,"status":728,"phases":1376,"primaryCompletion":1377,"completion":1378,"start":1379,"enrollment":464,"conditions":1380,"interventions":1382},"NCT00439166","Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid",[89],"2010-04","2010-12","2007-02",[1381],"Alzheimer's Disease",[1383,1384],"doxycycline","rifampicin",{"trials":1386,"activeCount":98},[],{"trials":1388,"activeCount":98},[],{"intervention":1390,"totalTrials":94,"cells":1391},"Mannitol",{"EARLY_PHASE1":1392,"PHASE1":1394,"PHASE2":1396,"PHASE3":1398,"PHASE4":1409,"NA":1411},{"trials":1393,"activeCount":98},[],{"trials":1395,"activeCount":98},[],{"trials":1397,"activeCount":98},[],{"trials":1399,"activeCount":98},[1400],{"nctId":1401,"briefTitle":1402,"status":167,"phases":1403,"primaryCompletion":1404,"completion":1404,"start":1404,"enrollment":98,"conditions":1405,"interventions":1408},"NCT04870073","Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery",[89],"2022-09-21",[1406,18,1407],"Hemodilution","Fluid Overload",[1390],{"trials":1410,"activeCount":98},[],{"trials":1412,"activeCount":98},[],{"intervention":1414,"totalTrials":94,"cells":1415},"budesonide",{"EARLY_PHASE1":1416,"PHASE1":1418,"PHASE2":1420,"PHASE3":1422,"PHASE4":1433,"NA":1435},{"trials":1417,"activeCount":98},[],{"trials":1419,"activeCount":98},[],{"trials":1421,"activeCount":98},[],{"trials":1423,"activeCount":98},[1424],{"nctId":1425,"briefTitle":1426,"status":728,"phases":1427,"primaryCompletion":1428,"completion":1428,"start":1339,"enrollment":1429,"conditions":1430,"interventions":1431},"NCT00462592","Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction",[89],"2009-06",18,[15],[1414,1432],"montelukast",{"trials":1434,"activeCount":98},[],{"trials":1436,"activeCount":98},[],{"intervention":1432,"totalTrials":94,"cells":1438},{"EARLY_PHASE1":1439,"PHASE1":1441,"PHASE2":1443,"PHASE3":1445,"PHASE4":1451,"NA":1453},{"trials":1440,"activeCount":98},[],{"trials":1442,"activeCount":98},[],{"trials":1444,"activeCount":98},[],{"trials":1446,"activeCount":98},[1447],{"nctId":1425,"briefTitle":1426,"status":728,"phases":1448,"primaryCompletion":1428,"completion":1428,"start":1339,"enrollment":1429,"conditions":1449,"interventions":1450},[89],[15],[1414,1432],{"trials":1452,"activeCount":98},[],{"trials":1454,"activeCount":98},[],{"intervention":1456,"totalTrials":94,"cells":1457},"ciclesonide",{"EARLY_PHASE1":1458,"PHASE1":1460,"PHASE2":1462,"PHASE3":1464,"PHASE4":1474,"NA":1476},{"trials":1459,"activeCount":98},[],{"trials":1461,"activeCount":98},[],{"trials":1463,"activeCount":98},[],{"trials":1465,"activeCount":98},[1466],{"nctId":1467,"briefTitle":1468,"status":728,"phases":1469,"primaryCompletion":1470,"completion":1470,"start":1471,"enrollment":638,"conditions":1472,"interventions":1473},"NCT00525772","Effect of Ciclesonide on Exercise Induced Bronchoconstriction",[89],"2007-11","2001-11",[15],[1456,1456],{"trials":1475,"activeCount":98},[],{"trials":1477,"activeCount":98},[],{"intervention":1479,"totalTrials":94,"cells":1480},"Fondaparinux",{"EARLY_PHASE1":1481,"PHASE1":1483,"PHASE2":1485,"PHASE3":1487,"PHASE4":1496,"NA":1498},{"trials":1482,"activeCount":98},[],{"trials":1484,"activeCount":98},[],{"trials":1486,"activeCount":98},[],{"trials":1488,"activeCount":98},[1489],{"nctId":1490,"briefTitle":1491,"status":782,"phases":1492,"enrollment":464,"conditions":1493,"interventions":1495},"NCT00474591","Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study",[89],[1494],"Coronary Bypass Graft Failure\u002FOcclusion",[1479],{"trials":1497,"activeCount":98},[],{"trials":1499,"activeCount":98},[],{"intervention":1501,"totalTrials":94,"cells":1502},"bosentan",{"EARLY_PHASE1":1503,"PHASE1":1505,"PHASE2":1507,"PHASE3":1509,"PHASE4":1520,"NA":1522},{"trials":1504,"activeCount":98},[],{"trials":1506,"activeCount":98},[],{"trials":1508,"activeCount":98},[],{"trials":1510,"activeCount":98},[1511],{"nctId":1512,"briefTitle":1513,"status":782,"phases":1514,"primaryCompletion":1377,"completion":1377,"start":1327,"enrollment":1515,"conditions":1516,"interventions":1519},"NCT00864201","A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease",[89],10,[1517,1518],"Hypertension, Pulmonary","Connective Tissue Disease",[1501],{"trials":1521,"activeCount":98},[],{"trials":1523,"activeCount":98},[],{"intervention":1525,"totalTrials":94,"cells":1526},"Morphine",{"EARLY_PHASE1":1527,"PHASE1":1529,"PHASE2":1531,"PHASE3":1533,"PHASE4":1545,"NA":1547},{"trials":1528,"activeCount":98},[],{"trials":1530,"activeCount":98},[],{"trials":1532,"activeCount":98},[],{"trials":1534,"activeCount":98},[1535],{"nctId":1536,"briefTitle":1537,"status":782,"phases":1538,"primaryCompletion":1539,"start":1540,"enrollment":615,"conditions":1541,"interventions":1543},"NCT01680939","Investigating the Safety of Post-surgical Analgesics in Children With Obstructive Sleep Apnea",[89],"2013-12","2012-05",[1542],"Pediatric Obstructive Sleep Apnea Syndrome",[1525,1544],"Ibuprofen",{"trials":1546,"activeCount":98},[],{"trials":1548,"activeCount":98},[],{"intervention":1544,"totalTrials":94,"cells":1550},{"EARLY_PHASE1":1551,"PHASE1":1553,"PHASE2":1555,"PHASE3":1557,"PHASE4":1563,"NA":1565},{"trials":1552,"activeCount":98},[],{"trials":1554,"activeCount":98},[],{"trials":1556,"activeCount":98},[],{"trials":1558,"activeCount":98},[1559],{"nctId":1536,"briefTitle":1537,"status":782,"phases":1560,"primaryCompletion":1539,"start":1540,"enrollment":615,"conditions":1561,"interventions":1562},[89],[1542],[1525,1544],{"trials":1564,"activeCount":98},[],{"trials":1566,"activeCount":98},[],{"intervention":1568,"totalTrials":94,"cells":1569},"Active Clonidine",{"EARLY_PHASE1":1570,"PHASE1":1572,"PHASE2":1574,"PHASE3":1576,"PHASE4":1588,"NA":1590},{"trials":1571,"activeCount":98},[],{"trials":1573,"activeCount":98},[],{"trials":1575,"activeCount":98},[],{"trials":1577,"activeCount":98},[1578],{"nctId":1579,"briefTitle":1580,"status":728,"phases":1581,"primaryCompletion":1292,"completion":1582,"start":1583,"enrollment":1584,"conditions":1585,"interventions":1586},"NCT01082874","PeriOperative ISchemic Evaluation-2 Trial",[89],"2015-01","2010-07",10010,[29],[1568,1587],"Active ASA",{"trials":1589,"activeCount":98},[],{"trials":1591,"activeCount":98},[],{"intervention":1587,"totalTrials":94,"cells":1593},{"EARLY_PHASE1":1594,"PHASE1":1596,"PHASE2":1598,"PHASE3":1600,"PHASE4":1606,"NA":1608},{"trials":1595,"activeCount":98},[],{"trials":1597,"activeCount":98},[],{"trials":1599,"activeCount":98},[],{"trials":1601,"activeCount":98},[1602],{"nctId":1579,"briefTitle":1580,"status":728,"phases":1603,"primaryCompletion":1292,"completion":1582,"start":1583,"enrollment":1584,"conditions":1604,"interventions":1605},[89],[29],[1568,1587],{"trials":1607,"activeCount":98},[],{"trials":1609,"activeCount":98},[],{"intervention":1611,"totalTrials":94,"cells":1612},"Povidone-Iodine Lavage Solution",{"EARLY_PHASE1":1613,"PHASE1":1615,"PHASE2":1617,"PHASE3":1619,"PHASE4":1635,"NA":1637},{"trials":1614,"activeCount":98},[],{"trials":1616,"activeCount":98},[],{"trials":1618,"activeCount":98},[],{"trials":1620,"activeCount":98},[1621],{"nctId":1622,"briefTitle":1623,"status":728,"phases":1624,"primaryCompletion":1625,"completion":1626,"start":1627,"enrollment":1628,"conditions":1629,"interventions":1631},"NCT05084378","Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement",[89],"2024-08-04","2024-10-28","2022-03-11",495,[512,1630],"Draining Wound",[1611,1632,1633,1634],"Chlorhexidine Lavage Solution","Topical Antibiotic","Saline Lavage Solution",{"trials":1636,"activeCount":98},[],{"trials":1638,"activeCount":98},[],{"intervention":1632,"totalTrials":94,"cells":1640},{"EARLY_PHASE1":1641,"PHASE1":1643,"PHASE2":1645,"PHASE3":1647,"PHASE4":1653,"NA":1655},{"trials":1642,"activeCount":98},[],{"trials":1644,"activeCount":98},[],{"trials":1646,"activeCount":98},[],{"trials":1648,"activeCount":98},[1649],{"nctId":1622,"briefTitle":1623,"status":728,"phases":1650,"primaryCompletion":1625,"completion":1626,"start":1627,"enrollment":1628,"conditions":1651,"interventions":1652},[89],[512,1630],[1611,1632,1633,1634],{"trials":1654,"activeCount":98},[],{"trials":1656,"activeCount":98},[],{"intervention":1633,"totalTrials":94,"cells":1658},{"EARLY_PHASE1":1659,"PHASE1":1661,"PHASE2":1663,"PHASE3":1665,"PHASE4":1671,"NA":1673},{"trials":1660,"activeCount":98},[],{"trials":1662,"activeCount":98},[],{"trials":1664,"activeCount":98},[],{"trials":1666,"activeCount":98},[1667],{"nctId":1622,"briefTitle":1623,"status":728,"phases":1668,"primaryCompletion":1625,"completion":1626,"start":1627,"enrollment":1628,"conditions":1669,"interventions":1670},[89],[512,1630],[1611,1632,1633,1634],{"trials":1672,"activeCount":98},[],{"trials":1674,"activeCount":98},[],{"intervention":1634,"totalTrials":94,"cells":1676},{"EARLY_PHASE1":1677,"PHASE1":1679,"PHASE2":1681,"PHASE3":1683,"PHASE4":1689,"NA":1691},{"trials":1678,"activeCount":98},[],{"trials":1680,"activeCount":98},[],{"trials":1682,"activeCount":98},[],{"trials":1684,"activeCount":98},[1685],{"nctId":1622,"briefTitle":1623,"status":728,"phases":1686,"primaryCompletion":1625,"completion":1626,"start":1627,"enrollment":1628,"conditions":1687,"interventions":1688},[89],[512,1630],[1611,1632,1633,1634],{"trials":1690,"activeCount":98},[],{"trials":1692,"activeCount":98},[],{"intervention":1694,"totalTrials":94,"cells":1695},"Metoprolol controlled release",{"EARLY_PHASE1":1696,"PHASE1":1698,"PHASE2":1700,"PHASE3":1702,"PHASE4":1715,"NA":1717},{"trials":1697,"activeCount":98},[],{"trials":1699,"activeCount":98},[],{"trials":1701,"activeCount":98},[],{"trials":1703,"activeCount":98},[1704],{"nctId":1705,"briefTitle":1706,"status":203,"phases":1707,"primaryCompletion":1708,"completion":1709,"start":1710,"enrollment":1711,"conditions":1712,"interventions":1714},"NCT00182039","POISE Trial: Perioperative Ischemic Evaluation Study",[89],"2007-07","2007-08","2002-10",8351,[1713],"Cardiovascular Diseases",[1694],{"trials":1716,"activeCount":98},[],{"trials":1718,"activeCount":98},[],{"intervention":1720,"totalTrials":94,"cells":1721},"Ketorolac Tromethamine",{"EARLY_PHASE1":1722,"PHASE1":1724,"PHASE2":1726,"PHASE3":1728,"PHASE4":1746,"NA":1748},{"trials":1723,"activeCount":98},[],{"trials":1725,"activeCount":98},[],{"trials":1727,"activeCount":98},[],{"trials":1729,"activeCount":98},[1730],{"nctId":1731,"briefTitle":1732,"status":728,"phases":1733,"primaryCompletion":1734,"completion":1735,"start":1736,"enrollment":1737,"conditions":1738,"interventions":1745},"NCT05641363","Comparison of Ketorolac at Three Doses in Children With Acute Pain",[89],"2025-04-24","2025-05-06","2023-06-01",171,[1739,1740,1741,1742,1743,1744],"Acute Pain","Abdominal Pain","Migraine","Appendicitis Acute","Renal Colic","Biliary Colic",[1720],{"trials":1747,"activeCount":98},[],{"trials":1749,"activeCount":98},[],{"intervention":1751,"totalTrials":94,"cells":1752},"Probiotic",{"EARLY_PHASE1":1753,"PHASE1":1755,"PHASE2":1757,"PHASE3":1759,"PHASE4":1772,"NA":1774},{"trials":1754,"activeCount":98},[],{"trials":1756,"activeCount":98},[],{"trials":1758,"activeCount":98},[],{"trials":1760,"activeCount":98},[1761],{"nctId":1762,"briefTitle":1763,"status":728,"phases":1764,"primaryCompletion":1765,"completion":1766,"start":1767,"enrollment":1768,"conditions":1769,"interventions":1771},"NCT02803827","Optimizing the Management of Acute Diarrhoeal Disease",[89],"2019-01","2019-02","2016-06",276,[1770],"Acute Gastroenteritis",[1751],{"trials":1773,"activeCount":98},[],{"trials":1775,"activeCount":98},[],{"intervention":1777,"totalTrials":94,"cells":1778},"Atenolol",{"EARLY_PHASE1":1779,"PHASE1":1781,"PHASE2":1783,"PHASE3":1785,"PHASE4":1799,"NA":1801},{"trials":1780,"activeCount":98},[],{"trials":1782,"activeCount":98},[],{"trials":1784,"activeCount":98},[],{"trials":1786,"activeCount":98},[1787],{"nctId":1788,"briefTitle":1789,"status":203,"phases":1790,"primaryCompletion":1791,"completion":1792,"start":1793,"enrollment":1794,"conditions":1795,"interventions":1797},"NCT01202721","Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)",[89],"2016-04-19","2016-11","2011-06",85,[1796],"Cardiac Disease",[1777,1798],"Telmisartan",{"trials":1800,"activeCount":98},[],{"trials":1802,"activeCount":98},[],{"intervention":1798,"totalTrials":94,"cells":1804},{"EARLY_PHASE1":1805,"PHASE1":1807,"PHASE2":1809,"PHASE3":1811,"PHASE4":1817,"NA":1819},{"trials":1806,"activeCount":98},[],{"trials":1808,"activeCount":98},[],{"trials":1810,"activeCount":98},[],{"trials":1812,"activeCount":98},[1813],{"nctId":1788,"briefTitle":1789,"status":203,"phases":1814,"primaryCompletion":1791,"completion":1792,"start":1793,"enrollment":1794,"conditions":1815,"interventions":1816},[89],[1796],[1777,1798],{"trials":1818,"activeCount":98},[],{"trials":1820,"activeCount":98},[],{"intervention":1384,"totalTrials":94,"cells":1822},{"EARLY_PHASE1":1823,"PHASE1":1825,"PHASE2":1827,"PHASE3":1829,"PHASE4":1835,"NA":1837},{"trials":1824,"activeCount":98},[],{"trials":1826,"activeCount":98},[],{"trials":1828,"activeCount":98},[],{"trials":1830,"activeCount":98},[1831],{"nctId":1374,"briefTitle":1375,"status":728,"phases":1832,"primaryCompletion":1377,"completion":1378,"start":1379,"enrollment":464,"conditions":1833,"interventions":1834},[89],[1381],[1383,1384],{"trials":1836,"activeCount":98},[],{"trials":1838,"activeCount":98},[],{"intervention":1840,"totalTrials":94,"cells":1841},"Convalescent plasma",{"EARLY_PHASE1":1842,"PHASE1":1844,"PHASE2":1846,"PHASE3":1848,"PHASE4":1861,"NA":1863},{"trials":1843,"activeCount":98},[],{"trials":1845,"activeCount":98},[],{"trials":1847,"activeCount":98},[],{"trials":1849,"activeCount":98},[1850],{"nctId":1851,"briefTitle":1852,"status":203,"phases":1853,"primaryCompletion":1854,"completion":1855,"start":1856,"enrollment":1857,"conditions":1858,"interventions":1860},"NCT04348656","CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)",[89],"2021-03-05","2021-06-16","2020-03-14",940,[1859],"COVID-19",[1840],{"trials":1862,"activeCount":98},[],{"trials":1864,"activeCount":98},[],{"intervention":1866,"totalTrials":94,"cells":1867},"Pregabalin 300 mg",{"EARLY_PHASE1":1868,"PHASE1":1870,"PHASE2":1872,"PHASE3":1874,"PHASE4":1889,"NA":1891},{"trials":1869,"activeCount":98},[],{"trials":1871,"activeCount":98},[],{"trials":1873,"activeCount":98},[],{"trials":1875,"activeCount":98},[1876],{"nctId":1877,"briefTitle":1878,"status":203,"phases":1879,"primaryCompletion":1880,"completion":1880,"start":1881,"enrollment":1882,"conditions":1883,"interventions":1885},"NCT04517110","Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery",[89],"2022-09-07","2021-04-09",17,[1884],"Opioid Use",[1866,1886,1887,1888],"Pregabalin 75 mg","Pregabalin 300 mg Placebo","Pregabalin 75 mg Placebo",{"trials":1890,"activeCount":98},[],{"trials":1892,"activeCount":98},[],{"intervention":1886,"totalTrials":94,"cells":1894},{"EARLY_PHASE1":1895,"PHASE1":1897,"PHASE2":1899,"PHASE3":1901,"PHASE4":1907,"NA":1909},{"trials":1896,"activeCount":98},[],{"trials":1898,"activeCount":98},[],{"trials":1900,"activeCount":98},[],{"trials":1902,"activeCount":98},[1903],{"nctId":1877,"briefTitle":1878,"status":203,"phases":1904,"primaryCompletion":1880,"completion":1880,"start":1881,"enrollment":1882,"conditions":1905,"interventions":1906},[89],[1884],[1866,1886,1887,1888],{"trials":1908,"activeCount":98},[],{"trials":1910,"activeCount":98},[],{"intervention":1887,"totalTrials":94,"cells":1912},{"EARLY_PHASE1":1913,"PHASE1":1915,"PHASE2":1917,"PHASE3":1919,"PHASE4":1925,"NA":1927},{"trials":1914,"activeCount":98},[],{"trials":1916,"activeCount":98},[],{"trials":1918,"activeCount":98},[],{"trials":1920,"activeCount":98},[1921],{"nctId":1877,"briefTitle":1878,"status":203,"phases":1922,"primaryCompletion":1880,"completion":1880,"start":1881,"enrollment":1882,"conditions":1923,"interventions":1924},[89],[1884],[1866,1886,1887,1888],{"trials":1926,"activeCount":98},[],{"trials":1928,"activeCount":98},[],{"intervention":1888,"totalTrials":94,"cells":1930},{"EARLY_PHASE1":1931,"PHASE1":1933,"PHASE2":1935,"PHASE3":1937,"PHASE4":1943,"NA":1945},{"trials":1932,"activeCount":98},[],{"trials":1934,"activeCount":98},[],{"trials":1936,"activeCount":98},[],{"trials":1938,"activeCount":98},[1939],{"nctId":1877,"briefTitle":1878,"status":203,"phases":1940,"primaryCompletion":1880,"completion":1880,"start":1881,"enrollment":1882,"conditions":1941,"interventions":1942},[89],[1884],[1866,1886,1887,1888],{"trials":1944,"activeCount":98},[],{"trials":1946,"activeCount":98},[],{"intervention":1948,"totalTrials":94,"cells":1949},"Paroxetine",{"EARLY_PHASE1":1950,"PHASE1":1952,"PHASE2":1954,"PHASE3":1956,"PHASE4":1965,"NA":1967},{"trials":1951,"activeCount":98},[],{"trials":1953,"activeCount":98},[],{"trials":1955,"activeCount":98},[],{"trials":1957,"activeCount":98},[1958],{"nctId":1959,"briefTitle":1960,"status":728,"phases":1961,"conditions":1962,"interventions":1964},"NCT00620581","Luteal Phase Administration of Paroxetine for the Treatment of PMDD",[89],[1963],"Premenstrual Dysphoric Disorder",[1948],{"trials":1966,"activeCount":98},[],{"trials":1968,"activeCount":98},[],{"intervention":1970,"totalTrials":94,"cells":1971},"0.9% NaCl",{"EARLY_PHASE1":1972,"PHASE1":1974,"PHASE2":1976,"PHASE3":1978,"PHASE4":1991,"NA":1993},{"trials":1973,"activeCount":98},[],{"trials":1975,"activeCount":98},[],{"trials":1977,"activeCount":98},[],{"trials":1979,"activeCount":98},[1980],{"nctId":1981,"briefTitle":1982,"status":728,"phases":1983,"primaryCompletion":1984,"completion":1984,"start":1049,"enrollment":1985,"conditions":1986,"interventions":1989},"NCT00734214","Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial",[89],"2009-12",258,[1987,1988],"Hyponatremia","Hypernatremia",[1970,1990],"0.45%NaCl",{"trials":1992,"activeCount":98},[],{"trials":1994,"activeCount":98},[],{"intervention":1990,"totalTrials":94,"cells":1996},{"EARLY_PHASE1":1997,"PHASE1":1999,"PHASE2":2001,"PHASE3":2003,"PHASE4":2009,"NA":2011},{"trials":1998,"activeCount":98},[],{"trials":2000,"activeCount":98},[],{"trials":2002,"activeCount":98},[],{"trials":2004,"activeCount":98},[2005],{"nctId":1981,"briefTitle":1982,"status":728,"phases":2006,"primaryCompletion":1984,"completion":1984,"start":1049,"enrollment":1985,"conditions":2007,"interventions":2008},[89],[1987,1988],[1970,1990],{"trials":2010,"activeCount":98},[],{"trials":2012,"activeCount":98},[],{"intervention":2014,"totalTrials":94,"cells":2015},"Ketorolac Tromethamine 10 MG\u002FML",{"EARLY_PHASE1":2016,"PHASE1":2018,"PHASE2":2020,"PHASE3":2022,"PHASE4":2039,"NA":2041},{"trials":2017,"activeCount":98},[],{"trials":2019,"activeCount":98},[],{"trials":2021,"activeCount":98},[],{"trials":2023,"activeCount":98},[2024],{"nctId":2025,"briefTitle":2026,"status":728,"phases":2027,"primaryCompletion":2028,"completion":2029,"start":2030,"enrollment":2031,"conditions":2032,"interventions":2037},"NCT04528563","Ketorolac for Moderate to Severe Abdominal Pain in Children",[89],"2023-02-05","2023-02-06","2021-05-05",105,[1740,2033,2034,2035,2036],"Appendicitis","Analgesia","Child, Only","Emergencies",[2014,2038],"Morphine Sulfate 10Mg\u002F1mL",{"trials":2040,"activeCount":98},[],{"trials":2042,"activeCount":98},[],{"intervention":2038,"totalTrials":94,"cells":2044},{"EARLY_PHASE1":2045,"PHASE1":2047,"PHASE2":2049,"PHASE3":2051,"PHASE4":2057,"NA":2059},{"trials":2046,"activeCount":98},[],{"trials":2048,"activeCount":98},[],{"trials":2050,"activeCount":98},[],{"trials":2052,"activeCount":98},[2053],{"nctId":2025,"briefTitle":2026,"status":728,"phases":2054,"primaryCompletion":2028,"completion":2029,"start":2030,"enrollment":2031,"conditions":2055,"interventions":2056},[89],[1740,2033,2034,2035,2036],[2014,2038],{"trials":2058,"activeCount":98},[],{"trials":2060,"activeCount":98},[],{"intervention":2062,"totalTrials":94,"cells":2063},"Desvenlafaxine Succinate",{"EARLY_PHASE1":2064,"PHASE1":2066,"PHASE2":2068,"PHASE3":2070,"PHASE4":2081,"NA":2083},{"trials":2065,"activeCount":98},[],{"trials":2067,"activeCount":98},[],{"trials":2069,"activeCount":98},[],{"trials":2071,"activeCount":98},[2072],{"nctId":2073,"briefTitle":2074,"status":782,"phases":2075,"primaryCompletion":1073,"completion":2076,"start":1428,"enrollment":2077,"conditions":2078,"interventions":2080},"NCT00888862","Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women",[89],"2012-10",90,[982,2079],"Menopausal Staging and Vasomotor Symptoms (for Females)",[2062],{"trials":2082,"activeCount":98},[],{"trials":2084,"activeCount":98},[],{"intervention":1308,"totalTrials":94,"cells":2086},{"EARLY_PHASE1":2087,"PHASE1":2089,"PHASE2":2091,"PHASE3":2093,"PHASE4":2099,"NA":2101},{"trials":2088,"activeCount":98},[],{"trials":2090,"activeCount":98},[],{"trials":2092,"activeCount":98},[],{"trials":2094,"activeCount":98},[2095],{"nctId":1301,"briefTitle":1302,"status":728,"phases":2096,"primaryCompletion":1048,"completion":1149,"start":946,"enrollment":1304,"conditions":2097,"interventions":2098},[89],[18,1306],[1270,1308],{"trials":2100,"activeCount":98},[],{"trials":2102,"activeCount":98},[],{"intervention":2104,"totalTrials":94,"cells":2105},"Zinc Supplement",{"EARLY_PHASE1":2106,"PHASE1":2108,"PHASE2":2110,"PHASE3":2112,"PHASE4":2126,"NA":2128},{"trials":2107,"activeCount":98},[],{"trials":2109,"activeCount":98},[],{"trials":2111,"activeCount":98},[],{"trials":2113,"activeCount":98},[2114],{"nctId":2115,"briefTitle":2116,"status":728,"phases":2117,"primaryCompletion":2118,"completion":2118,"start":2119,"enrollment":249,"conditions":2120,"interventions":2125},"NCT02126293","Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant",[89],"2017-01","2014-09",[2121,2122,2123,2124],"Renal Insufficiency, Chronic","Zinc Deficiency","Trace Element Excess","Trace Element Deficiency",[2104],{"trials":2127,"activeCount":98},[],{"trials":2129,"activeCount":98},[],{"intervention":2131,"totalTrials":94,"cells":2132},"Intravenous albumin",{"EARLY_PHASE1":2133,"PHASE1":2135,"PHASE2":2137,"PHASE3":2139,"PHASE4":2151,"NA":2153},{"trials":2134,"activeCount":98},[],{"trials":2136,"activeCount":98},[],{"trials":2138,"activeCount":98},[],{"trials":2140,"activeCount":98},[2141],{"nctId":2142,"briefTitle":2143,"status":728,"phases":2144,"primaryCompletion":2145,"completion":2145,"start":2119,"enrollment":9,"conditions":2146,"interventions":2149},"NCT02055872","Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial",[89],"2016-10",[2147,2148],"Edema","Hypoproteinemia",[2131,2150],"Normal saline",{"trials":2152,"activeCount":98},[],{"trials":2154,"activeCount":98},[],{"intervention":2150,"totalTrials":94,"cells":2156},{"EARLY_PHASE1":2157,"PHASE1":2159,"PHASE2":2161,"PHASE3":2163,"PHASE4":2169,"NA":2171},{"trials":2158,"activeCount":98},[],{"trials":2160,"activeCount":98},[],{"trials":2162,"activeCount":98},[],{"trials":2164,"activeCount":98},[2165],{"nctId":2142,"briefTitle":2143,"status":728,"phases":2166,"primaryCompletion":2145,"completion":2145,"start":2119,"enrollment":9,"conditions":2167,"interventions":2168},[89],[2147,2148],[2131,2150],{"trials":2170,"activeCount":98},[],{"trials":2172,"activeCount":98},[],{"intervention":2174,"totalTrials":213,"cells":2175},"Rituximab",{"EARLY_PHASE1":2176,"PHASE1":2178,"PHASE2":2180,"PHASE3":2200,"PHASE4":2202,"NA":2204},{"trials":2177,"activeCount":98},[],{"trials":2179,"activeCount":98},[],{"trials":2181,"activeCount":98},[2182,2190],{"nctId":2183,"briefTitle":2184,"status":728,"phases":2185,"primaryCompletion":1378,"completion":1793,"start":2186,"enrollment":354,"conditions":2187,"interventions":2189},"NCT00372892","Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)",[88],"2006-09",[2188],"Purpura, Thrombocytopenic, Idiopathic",[2174],{"nctId":2191,"briefTitle":2192,"status":782,"phases":2193,"primaryCompletion":2194,"completion":2194,"start":2195,"enrollment":354,"conditions":2196,"interventions":2199},"NCT00531089","Rituximab in Patients With Relapsed or Refractory TTP-HUS",[88],"2011-01","2007-12",[2197,2198],"Thrombotic Thrombocytopenic Purpura","Hemolytic Uremic Syndrome",[2174],{"trials":2201,"activeCount":98},[],{"trials":2203,"activeCount":98},[],{"trials":2205,"activeCount":98},[],{"intervention":2207,"totalTrials":94,"cells":2208},"apixaban dose reduction",{"EARLY_PHASE1":2209,"PHASE1":2211,"PHASE2":2213,"PHASE3":2223,"PHASE4":2225,"NA":2227},{"trials":2210,"activeCount":98},[],{"trials":2212,"activeCount":98},[],{"trials":2214,"activeCount":98},[2215],{"nctId":2216,"briefTitle":2217,"status":782,"phases":2218,"primaryCompletion":2219,"completion":2219,"start":2220,"enrollment":615,"conditions":2221,"interventions":2222},"NCT02809469","Apixaban Dose Reduction in Patients With Elevated Drug Levels",[88],"2018-08","2016-08",[1330],[2207],{"trials":2224,"activeCount":98},[],{"trials":2226,"activeCount":98},[],{"trials":2228,"activeCount":98},[],{"intervention":2230,"totalTrials":94,"cells":2231},"Antihistamine",{"EARLY_PHASE1":2232,"PHASE1":2234,"PHASE2":2236,"PHASE3":2247,"PHASE4":2249,"NA":2251},{"trials":2233,"activeCount":98},[],{"trials":2235,"activeCount":98},[],{"trials":2237,"activeCount":98},[2238],{"nctId":2239,"briefTitle":2240,"status":728,"phases":2241,"primaryCompletion":2242,"completion":2242,"start":1072,"enrollment":2243,"conditions":2244,"interventions":2246},"NCT01601522","Peanut Allergy Oral Immunotherapy Desensitization",[88],"2021-09",43,[2245],"Peanut Allergy",[2230],{"trials":2248,"activeCount":98},[],{"trials":2250,"activeCount":98},[],{"trials":2252,"activeCount":98},[],{"intervention":2254,"totalTrials":94,"cells":2255},"R-albuterol, S-albuterol",{"EARLY_PHASE1":2256,"PHASE1":2258,"PHASE2":2260,"PHASE3":2271,"PHASE4":2273,"NA":2275},{"trials":2257,"activeCount":98},[],{"trials":2259,"activeCount":98},[],{"trials":2261,"activeCount":98},[2262],{"nctId":2263,"briefTitle":2264,"status":728,"phases":2265,"primaryCompletion":1048,"completion":2266,"start":2267,"enrollment":2268,"conditions":2269,"interventions":2270},"NCT00320034","Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma",[88],"2009-11","2006-04",15,[15],[2254],{"trials":2272,"activeCount":98},[],{"trials":2274,"activeCount":98},[],{"trials":2276,"activeCount":98},[],{"intervention":2278,"totalTrials":94,"cells":2279},"Hold ACEI or ARB",{"EARLY_PHASE1":2280,"PHASE1":2282,"PHASE2":2284,"PHASE3":2295,"PHASE4":2297,"NA":2299},{"trials":2281,"activeCount":98},[],{"trials":2283,"activeCount":98},[],{"trials":2285,"activeCount":98},[2286],{"nctId":2287,"briefTitle":2288,"status":728,"phases":2289,"primaryCompletion":2290,"completion":2290,"start":946,"enrollment":2291,"conditions":2292,"interventions":2294},"NCT00317252","Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization",[88],"2012-03",220,[2293],"Kidney Failure",[2278],{"trials":2296,"activeCount":98},[],{"trials":2298,"activeCount":98},[],{"trials":2300,"activeCount":98},[],{"intervention":2302,"totalTrials":94,"cells":2303},"Tiotropium",{"EARLY_PHASE1":2304,"PHASE1":2306,"PHASE2":2308,"PHASE3":2319,"PHASE4":2321,"NA":2323},{"trials":2305,"activeCount":98},[],{"trials":2307,"activeCount":98},[],{"trials":2309,"activeCount":98},[2310],{"nctId":2311,"briefTitle":2312,"status":782,"phases":2313,"primaryCompletion":1767,"completion":2220,"start":2314,"enrollment":8,"conditions":2315,"interventions":2318},"NCT01172925","Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer",[88],"2010-11",[2316,2317],"NSCLC","Dyspnea",[2302],{"trials":2320,"activeCount":98},[],{"trials":2322,"activeCount":98},[],{"trials":2324,"activeCount":98},[],{"intervention":2326,"totalTrials":94,"cells":2327},"Human recombinant growth hormone",{"EARLY_PHASE1":2328,"PHASE1":2330,"PHASE2":2332,"PHASE3":2342,"PHASE4":2344,"NA":2346},{"trials":2329,"activeCount":98},[],{"trials":2331,"activeCount":98},[],{"trials":2333,"activeCount":98},[2334],{"nctId":2335,"briefTitle":2336,"status":728,"phases":2337,"completion":2338,"start":2339,"enrollment":732,"conditions":2340,"interventions":2341},"NCT00182169","Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure",[88],"2005-06","1997-07",[31],[2326],{"trials":2343,"activeCount":98},[],{"trials":2345,"activeCount":98},[],{"trials":2347,"activeCount":98},[],{"intervention":2349,"totalTrials":94,"cells":2350},"domperidone",{"EARLY_PHASE1":2351,"PHASE1":2353,"PHASE2":2355,"PHASE3":2366,"PHASE4":2368,"NA":2370},{"trials":2352,"activeCount":98},[],{"trials":2354,"activeCount":98},[],{"trials":2356,"activeCount":98},[2357],{"nctId":2358,"briefTitle":2359,"status":203,"phases":2360,"completion":2361,"start":2186,"enrollment":2362,"conditions":2363,"interventions":2365},"NCT00284024","Effectiveness of Domperidone to Increase Breastmilk Supply in Mothers With Low Supply",[88],"2007-09",45,[2364],"Insufficient Breastmilk Production",[2349],{"trials":2367,"activeCount":98},[],{"trials":2369,"activeCount":98},[],{"trials":2371,"activeCount":98},[],{"intervention":2373,"totalTrials":94,"cells":2374},"Dosing warfarin every 12 weeks, sham INRs 2 out of 3 times",{"EARLY_PHASE1":2375,"PHASE1":2377,"PHASE2":2379,"PHASE3":2391,"PHASE4":2393,"NA":2395},{"trials":2376,"activeCount":98},[],{"trials":2378,"activeCount":98},[],{"trials":2380,"activeCount":98},[2381],{"nctId":2382,"briefTitle":2383,"status":728,"phases":2384,"primaryCompletion":868,"completion":2385,"start":2386,"enrollment":574,"conditions":2387,"interventions":2390},"NCT00356759","Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients",[88],"2010-02","2006-12",[1330,2388,2389],"Heart Valve Diseases","Venous Thrombosis",[2373],{"trials":2392,"activeCount":98},[],{"trials":2394,"activeCount":98},[],{"trials":2396,"activeCount":98},[],{"intervention":1369,"totalTrials":94,"cells":2398},{"EARLY_PHASE1":2399,"PHASE1":2401,"PHASE2":2403,"PHASE3":2409,"PHASE4":2411,"NA":2413},{"trials":2400,"activeCount":98},[],{"trials":2402,"activeCount":98},[],{"trials":2404,"activeCount":98},[2405],{"nctId":1359,"briefTitle":1360,"status":728,"phases":2406,"primaryCompletion":1362,"completion":1363,"start":1364,"enrollment":1365,"conditions":2407,"interventions":2408},[88],[1367],[1369,1350,1370],{"trials":2410,"activeCount":98},[],{"trials":2412,"activeCount":98},[],{"trials":2414,"activeCount":98},[],{"intervention":1370,"totalTrials":94,"cells":2416},{"EARLY_PHASE1":2417,"PHASE1":2419,"PHASE2":2421,"PHASE3":2427,"PHASE4":2429,"NA":2431},{"trials":2418,"activeCount":98},[],{"trials":2420,"activeCount":98},[],{"trials":2422,"activeCount":98},[2423],{"nctId":1359,"briefTitle":1360,"status":728,"phases":2424,"primaryCompletion":1362,"completion":1363,"start":1364,"enrollment":1365,"conditions":2425,"interventions":2426},[88],[1367],[1369,1350,1370],{"trials":2428,"activeCount":98},[],{"trials":2430,"activeCount":98},[],{"trials":2432,"activeCount":98},[],{"intervention":2434,"totalTrials":94,"cells":2435},"DC-Tn-MUC1: autologous dendritic cells expressing Tn-MUC1",{"EARLY_PHASE1":2436,"PHASE1":2438,"PHASE2":2440,"PHASE3":2451,"PHASE4":2453,"NA":2455},{"trials":2437,"activeCount":98},[],{"trials":2439,"activeCount":98},[],{"trials":2441,"activeCount":98},[2442],{"nctId":2443,"briefTitle":2444,"status":728,"phases":2445,"primaryCompletion":2446,"completion":2447,"start":2448,"enrollment":111,"conditions":2449,"interventions":2450},"NCT00852007","A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1",[87,88],"2014-02","2016-02","2009-02",[113],[2434],{"trials":2452,"activeCount":98},[],{"trials":2454,"activeCount":98},[],{"trials":2456,"activeCount":98},[],{"intervention":2458,"totalTrials":94,"cells":2459},"CBD",{"EARLY_PHASE1":2460,"PHASE1":2462,"PHASE2":2464,"PHASE3":2477,"PHASE4":2479,"NA":2481},{"trials":2461,"activeCount":98},[],{"trials":2463,"activeCount":98},[],{"trials":2465,"activeCount":98},[2466],{"nctId":2467,"briefTitle":2468,"status":782,"phases":2469,"primaryCompletion":2470,"completion":2470,"start":2471,"enrollment":2472,"conditions":2473,"interventions":2475},"NCT03635593","Cannabis Oil for Chronic Non-Cancer Pain Treatment",[88],"2021-01-30","2019-01-01",309,[2474],"Chronic Non-cancer Pain",[2458,2476],"CBD+THC",{"trials":2478,"activeCount":98},[],{"trials":2480,"activeCount":98},[],{"trials":2482,"activeCount":98},[],{"intervention":2476,"totalTrials":94,"cells":2484},{"EARLY_PHASE1":2485,"PHASE1":2487,"PHASE2":2489,"PHASE3":2495,"PHASE4":2497,"NA":2499},{"trials":2486,"activeCount":98},[],{"trials":2488,"activeCount":98},[],{"trials":2490,"activeCount":98},[2491],{"nctId":2467,"briefTitle":2468,"status":782,"phases":2492,"primaryCompletion":2470,"completion":2470,"start":2471,"enrollment":2472,"conditions":2493,"interventions":2494},[88],[2474],[2458,2476],{"trials":2496,"activeCount":98},[],{"trials":2498,"activeCount":98},[],{"trials":2500,"activeCount":98},[],{"intervention":2502,"totalTrials":94,"cells":2503},"Botulinum toxin type A",{"EARLY_PHASE1":2504,"PHASE1":2506,"PHASE2":2508,"PHASE3":2520,"PHASE4":2522,"NA":2524},{"trials":2505,"activeCount":98},[],{"trials":2507,"activeCount":98},[],{"trials":2509,"activeCount":98},[2510],{"nctId":2511,"briefTitle":2512,"status":167,"phases":2513,"primaryCompletion":2514,"completion":2515,"start":2516,"enrollment":98,"conditions":2517,"interventions":2519},"NCT03903653","Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity",[88],"2019-11-01","2019-12-01","2019-09-01",[2518],"Spastic Foot",[2502],{"trials":2521,"activeCount":98},[],{"trials":2523,"activeCount":98},[],{"trials":2525,"activeCount":98},[],{"intervention":2527,"totalTrials":94,"cells":2528},"Labetalol",{"EARLY_PHASE1":2529,"PHASE1":2531,"PHASE2":2533,"PHASE3":2551,"PHASE4":2553,"NA":2555},{"trials":2530,"activeCount":98},[],{"trials":2532,"activeCount":98},[],{"trials":2534,"activeCount":98},[2535],{"nctId":2536,"briefTitle":2537,"status":728,"phases":2538,"primaryCompletion":2539,"completion":2540,"start":2541,"enrollment":333,"conditions":2542,"interventions":2548},"NCT04484350","Blood Pressure Management in Stroke Following Endovascular Treatment",[88],"2023-02-04","2023-05-04","2020-10-23",[2543,2544,2545,2546,2547],"Stroke, Acute","Vessels; Occlusion","Blood Pressure","Endovascular Thrombectomy","Mechanical Thrombectomy",[2527,2549,2550],"Hydralazine","Enalapril",{"trials":2552,"activeCount":98},[],{"trials":2554,"activeCount":98},[],{"trials":2556,"activeCount":98},[],{"intervention":2549,"totalTrials":94,"cells":2558},{"EARLY_PHASE1":2559,"PHASE1":2561,"PHASE2":2563,"PHASE3":2569,"PHASE4":2571,"NA":2573},{"trials":2560,"activeCount":98},[],{"trials":2562,"activeCount":98},[],{"trials":2564,"activeCount":98},[2565],{"nctId":2536,"briefTitle":2537,"status":728,"phases":2566,"primaryCompletion":2539,"completion":2540,"start":2541,"enrollment":333,"conditions":2567,"interventions":2568},[88],[2543,2544,2545,2546,2547],[2527,2549,2550],{"trials":2570,"activeCount":98},[],{"trials":2572,"activeCount":98},[],{"trials":2574,"activeCount":98},[],{"intervention":2550,"totalTrials":94,"cells":2576},{"EARLY_PHASE1":2577,"PHASE1":2579,"PHASE2":2581,"PHASE3":2587,"PHASE4":2589,"NA":2591},{"trials":2578,"activeCount":98},[],{"trials":2580,"activeCount":98},[],{"trials":2582,"activeCount":98},[2583],{"nctId":2536,"briefTitle":2537,"status":728,"phases":2584,"primaryCompletion":2539,"completion":2540,"start":2541,"enrollment":333,"conditions":2585,"interventions":2586},[88],[2543,2544,2545,2546,2547],[2527,2549,2550],{"trials":2588,"activeCount":98},[],{"trials":2590,"activeCount":98},[],{"trials":2592,"activeCount":98},[],{"intervention":2594,"totalTrials":94,"cells":2595},"CD34+ derived DCs",{"EARLY_PHASE1":2596,"PHASE1":2598,"PHASE2":2608,"PHASE3":2610,"PHASE4":2612,"NA":2614},{"trials":2597,"activeCount":98},[],{"trials":2599,"activeCount":98},[2600],{"nctId":2601,"briefTitle":2602,"status":728,"phases":2603,"primaryCompletion":1540,"completion":1540,"start":2604,"enrollment":27,"conditions":2605,"interventions":2607},"NCT00197522","Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2",[87],"2004-10",[2606],"Breast Neoplasms",[2594],{"trials":2609,"activeCount":98},[],{"trials":2611,"activeCount":98},[],{"trials":2613,"activeCount":98},[],{"trials":2615,"activeCount":98},[],{"intervention":2617,"totalTrials":94,"cells":2618},"Caffeine Pill",{"EARLY_PHASE1":2619,"PHASE1":2631,"PHASE2":2633,"PHASE3":2635,"PHASE4":2637,"NA":2639},{"trials":2620,"activeCount":98},[2621],{"nctId":2622,"briefTitle":2623,"status":782,"phases":2624,"primaryCompletion":2625,"completion":353,"start":2626,"enrollment":2627,"conditions":2628,"interventions":2630},"NCT06359197","Effect of Caffeine Consumption on Protein Biomarkers and Cardiovascular Disease",[86],"2024-08-10","2024-04-08",36,[2629],"Healthy",[2617],{"trials":2632,"activeCount":98},[],{"trials":2634,"activeCount":98},[],{"trials":2636,"activeCount":98},[],{"trials":2638,"activeCount":98},[],{"trials":2640,"activeCount":98},[],{"intervention":2642,"totalTrials":94,"cells":2643},"Aeroallergen",{"EARLY_PHASE1":2644,"PHASE1":2654,"PHASE2":2656,"PHASE3":2658,"PHASE4":2660,"NA":2662},{"trials":2645,"activeCount":98},[2646],{"nctId":2647,"briefTitle":2648,"status":728,"phases":2649,"primaryCompletion":1148,"completion":1149,"start":2650,"enrollment":2651,"conditions":2652,"interventions":2653},"NCT00625989","The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics",[86],"2008-02",12,[15],[2642],{"trials":2655,"activeCount":98},[],{"trials":2657,"activeCount":98},[],{"trials":2659,"activeCount":98},[],{"trials":2661,"activeCount":98},[],{"trials":2663,"activeCount":98},[],{"intervention":175,"totalTrials":94,"cells":2665},{"EARLY_PHASE1":2666,"PHASE1":2672,"PHASE2":2674,"PHASE3":2676,"PHASE4":2678,"NA":2680},{"trials":2667,"activeCount":98},[2668],{"nctId":165,"briefTitle":166,"status":167,"phases":2669,"primaryCompletion":169,"completion":169,"start":170,"enrollment":98,"conditions":2670,"interventions":2671},[86],[172,173],[159,175,176],{"trials":2673,"activeCount":98},[],{"trials":2675,"activeCount":98},[],{"trials":2677,"activeCount":98},[],{"trials":2679,"activeCount":98},[],{"trials":2681,"activeCount":98},[],{"intervention":176,"totalTrials":94,"cells":2683},{"EARLY_PHASE1":2684,"PHASE1":2690,"PHASE2":2692,"PHASE3":2694,"PHASE4":2696,"NA":2698},{"trials":2685,"activeCount":98},[2686],{"nctId":165,"briefTitle":166,"status":167,"phases":2687,"primaryCompletion":169,"completion":169,"start":170,"enrollment":98,"conditions":2688,"interventions":2689},[86],[172,173],[159,175,176],{"trials":2691,"activeCount":98},[],{"trials":2693,"activeCount":98},[],{"trials":2695,"activeCount":98},[],{"trials":2697,"activeCount":98},[],{"trials":2699,"activeCount":98},[],{"intervention":2701,"totalTrials":213,"cells":2702},"Fragmin",{"EARLY_PHASE1":2703,"PHASE1":2705,"PHASE2":2707,"PHASE3":2709,"PHASE4":2720,"NA":2722},{"trials":2704,"activeCount":98},[],{"trials":2706,"activeCount":98},[],{"trials":2708,"activeCount":98},[],{"trials":2710,"activeCount":98},[2711],{"nctId":2712,"briefTitle":2713,"status":728,"phases":2714,"completion":947,"start":2715,"enrollment":615,"conditions":2716,"interventions":2719},"NCT00182364","PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)",[89],"2003-02",[2717,2718],"Critically Ill","Deep Venous Thrombosis",[2701],{"trials":2721,"activeCount":98},[],{"trials":2723,"activeCount":98},[2724],{"nctId":2725,"briefTitle":2726,"status":728,"phases":2727,"completion":2728,"start":2729,"enrollment":2730,"conditions":2731,"interventions":2733},"NCT00138099","Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)",[],"2006-06","2004-07",140,[2732],"Renal Insufficiency",[2701],{"intervention":2735,"totalTrials":94,"cells":2736},"Amantadine",{"EARLY_PHASE1":2737,"PHASE1":2739,"PHASE2":2741,"PHASE3":2743,"PHASE4":2745,"NA":2747},{"trials":2738,"activeCount":98},[],{"trials":2740,"activeCount":98},[],{"trials":2742,"activeCount":98},[],{"trials":2744,"activeCount":98},[],{"trials":2746,"activeCount":98},[],{"trials":2748,"activeCount":98},[2749],{"nctId":2750,"briefTitle":2751,"status":782,"phases":2752,"primaryCompletion":2753,"completion":2754,"start":2755,"enrollment":1515,"conditions":2756,"interventions":2762},"NCT02566720","Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study",[91],"2016-12","2017-06","2016-01",[2757,2758,2759,2760,2761],"Acquired Brain Injury","Coma","Persistent Vegetative State","Minimally Conscious State","Traumatic Brain Injury",[2735],{"intervention":2764,"totalTrials":94,"cells":2765},"Gabapentin",{"EARLY_PHASE1":2766,"PHASE1":2768,"PHASE2":2770,"PHASE3":2772,"PHASE4":2774,"NA":2776},{"trials":2767,"activeCount":98},[],{"trials":2769,"activeCount":98},[],{"trials":2771,"activeCount":98},[],{"trials":2773,"activeCount":98},[],{"trials":2775,"activeCount":98},[],{"trials":2777,"activeCount":98},[2778],{"nctId":2779,"briefTitle":2780,"status":728,"phases":2781,"primaryCompletion":2782,"completion":2782,"start":2783,"enrollment":2784,"conditions":2785,"interventions":2788},"NCT00889148","Morphine COnsumption in Joint Replacement Patients, With and Without GaBapentin Treatment, a RandomIzed ControlLEd Study",[91],"2011-02","2007-10",103,[2786,2787],"Postoperative Pain","Total Hip Replacement",[2764],{"intervention":2790,"totalTrials":94,"cells":2791},"Creatine Monohydrate, Conjugated Linoleic Acid",{"EARLY_PHASE1":2792,"PHASE1":2794,"PHASE2":2796,"PHASE3":2798,"PHASE4":2800,"NA":2802},{"trials":2793,"activeCount":98},[],{"trials":2795,"activeCount":98},[],{"trials":2797,"activeCount":98},[],{"trials":2799,"activeCount":98},[],{"trials":2801,"activeCount":98},[],{"trials":2803,"activeCount":98},[2804],{"nctId":2805,"briefTitle":2806,"status":728,"phases":2807,"completion":2808,"start":2809,"enrollment":2810,"conditions":2811,"interventions":2813},"NCT00473902","Older Adult Training Study With Creatine and CLA",[91],"2004-09","2003-08",39,[2812],"Sarcopenia",[2790],{"intervention":2815,"totalTrials":94,"cells":2816},"Antiplatelet treatment",{"EARLY_PHASE1":2817,"PHASE1":2819,"PHASE2":2821,"PHASE3":2823,"PHASE4":2825,"NA":2827},{"trials":2818,"activeCount":98},[],{"trials":2820,"activeCount":98},[],{"trials":2822,"activeCount":98},[],{"trials":2824,"activeCount":98},[],{"trials":2826,"activeCount":98},[],{"trials":2828,"activeCount":98},[2829],{"nctId":2830,"briefTitle":2831,"status":782,"phases":2832,"primaryCompletion":2833,"completion":973,"start":2118,"enrollment":1515,"conditions":2834,"interventions":2838},"NCT03005704","Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets",[91],"2017-12",[2835,1270,2836,2837],"Ticagrelor","Platelet Dysfunction Due to Drugs","Transfusion",[2815],{"intervention":2840,"totalTrials":94,"cells":2841},"Pentastarch",{"EARLY_PHASE1":2842,"PHASE1":2844,"PHASE2":2846,"PHASE3":2848,"PHASE4":2850,"NA":2852},{"trials":2843,"activeCount":98},[],{"trials":2845,"activeCount":98},[],{"trials":2847,"activeCount":98},[],{"trials":2849,"activeCount":98},[],{"trials":2851,"activeCount":98},[],{"trials":2853,"activeCount":98},[2854],{"nctId":2855,"briefTitle":2856,"status":782,"phases":2857,"conditions":2858,"interventions":2861},"NCT00182377","Pentastarch Use in Cardiac Surgery",[91],[2859,2860],"Cardiac Surgery","Cardiopulmonary Bypass",[2840],{"intervention":2863,"totalTrials":94,"cells":2864},"Lidocaine",{"EARLY_PHASE1":2865,"PHASE1":2867,"PHASE2":2869,"PHASE3":2871,"PHASE4":2873,"NA":2875},{"trials":2866,"activeCount":98},[],{"trials":2868,"activeCount":98},[],{"trials":2870,"activeCount":98},[],{"trials":2872,"activeCount":98},[],{"trials":2874,"activeCount":98},[],{"trials":2876,"activeCount":98},[2877],{"nctId":2878,"briefTitle":2879,"status":782,"phases":2880,"primaryCompletion":2881,"completion":2881,"start":2882,"enrollment":2883,"conditions":2884,"interventions":2886},"NCT03249025","Lidocaine-Ketamine for Management of Chronic Pain",[91],"2018-09-01","2017-09-01",72,[2885],"Chronic Pain Syndrome",[2863,2887],"Ketamine",{"intervention":2887,"totalTrials":94,"cells":2889},{"EARLY_PHASE1":2890,"PHASE1":2892,"PHASE2":2894,"PHASE3":2896,"PHASE4":2898,"NA":2900},{"trials":2891,"activeCount":98},[],{"trials":2893,"activeCount":98},[],{"trials":2895,"activeCount":98},[],{"trials":2897,"activeCount":98},[],{"trials":2899,"activeCount":98},[],{"trials":2901,"activeCount":98},[2902],{"nctId":2878,"briefTitle":2879,"status":782,"phases":2903,"primaryCompletion":2881,"completion":2881,"start":2882,"enrollment":2883,"conditions":2904,"interventions":2905},[91],[2885],[2863,2887],{"intervention":2907,"totalTrials":94,"cells":2908},"Subcutaneous Lidocaine 2% (Xylocaine) without epinephrine",{"EARLY_PHASE1":2909,"PHASE1":2911,"PHASE2":2913,"PHASE3":2915,"PHASE4":2917,"NA":2919},{"trials":2910,"activeCount":98},[],{"trials":2912,"activeCount":98},[],{"trials":2914,"activeCount":98},[],{"trials":2916,"activeCount":98},[],{"trials":2918,"activeCount":98},[],{"trials":2920,"activeCount":98},[2921],{"nctId":2922,"briefTitle":2923,"status":728,"phases":2924,"primaryCompletion":2361,"completion":2361,"start":2925,"enrollment":2926,"conditions":2927,"interventions":2930},"NCT00465439","Safety\u002FEfficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal",[91],"2007-05",78,[2928,2929],"Syncope, Vasovagal","Pain Intensity",[2907],{"intervention":2932,"totalTrials":94,"cells":2933},"aspirin + clopidogrel",{"EARLY_PHASE1":2934,"PHASE1":2936,"PHASE2":2938,"PHASE3":2940,"PHASE4":2942,"NA":2944},{"trials":2935,"activeCount":98},[],{"trials":2937,"activeCount":98},[],{"trials":2939,"activeCount":98},[],{"trials":2941,"activeCount":98},[],{"trials":2943,"activeCount":98},[],{"trials":2945,"activeCount":98},[2946],{"nctId":2947,"briefTitle":2948,"status":728,"phases":2949,"primaryCompletion":2950,"completion":2950,"start":2951,"enrollment":111,"conditions":2952,"interventions":2953},"NCT00662467","Warfarin After Anterior ST-Elevation Myocardial Infarction",[91],"2008-01","2006-11",[1263],[2932,2954],"aspirin + clopidogrel + warfarin",{"intervention":2954,"totalTrials":94,"cells":2956},{"EARLY_PHASE1":2957,"PHASE1":2959,"PHASE2":2961,"PHASE3":2963,"PHASE4":2965,"NA":2967},{"trials":2958,"activeCount":98},[],{"trials":2960,"activeCount":98},[],{"trials":2962,"activeCount":98},[],{"trials":2964,"activeCount":98},[],{"trials":2966,"activeCount":98},[],{"trials":2968,"activeCount":98},[2969],{"nctId":2947,"briefTitle":2948,"status":728,"phases":2970,"primaryCompletion":2950,"completion":2950,"start":2951,"enrollment":111,"conditions":2971,"interventions":2972},[91],[1263],[2932,2954],{"intervention":2974,"totalTrials":94,"cells":2975},"Insulin",{"EARLY_PHASE1":2976,"PHASE1":2978,"PHASE2":2980,"PHASE3":2982,"PHASE4":2984,"NA":2986},{"trials":2977,"activeCount":98},[],{"trials":2979,"activeCount":98},[],{"trials":2981,"activeCount":98},[],{"trials":2983,"activeCount":98},[],{"trials":2985,"activeCount":98},[],{"trials":2987,"activeCount":98},[2988],{"nctId":2989,"briefTitle":2990,"status":728,"phases":2991,"completion":2992,"start":974,"enrollment":2993,"conditions":2994,"interventions":2997},"NCT00412126","Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI",[91],"2005-09",240,[2995,2996],"Diabetes Mellitus","Coronary Restenosis",[2974],{"intervention":2999,"totalTrials":94,"cells":3000},"Anastrozole",{"EARLY_PHASE1":3001,"PHASE1":3003,"PHASE2":3005,"PHASE3":3007,"PHASE4":3009,"NA":3011},{"trials":3002,"activeCount":98},[],{"trials":3004,"activeCount":98},[],{"trials":3006,"activeCount":98},[],{"trials":3008,"activeCount":98},[],{"trials":3010,"activeCount":98},[],{"trials":3012,"activeCount":98},[3013],{"nctId":3014,"briefTitle":3015,"status":728,"phases":3016,"primaryCompletion":1327,"completion":3017,"start":794,"enrollment":3018,"conditions":3019,"interventions":3020},"NCT00421447","Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole",[],"2009-08",58,[21],[2999],{"intervention":3022,"totalTrials":94,"cells":3023},"Aspirin 81 mg",{"EARLY_PHASE1":3024,"PHASE1":3026,"PHASE2":3028,"PHASE3":3030,"PHASE4":3032,"NA":3034},{"trials":3025,"activeCount":98},[],{"trials":3027,"activeCount":98},[],{"trials":3029,"activeCount":98},[],{"trials":3031,"activeCount":98},[],{"trials":3033,"activeCount":98},[],{"trials":3035,"activeCount":98},[3036],{"nctId":3037,"briefTitle":3038,"status":728,"phases":3039,"primaryCompletion":3040,"completion":3040,"start":3041,"enrollment":111,"conditions":3042,"interventions":3043},"NCT03424408","Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin",[91],"2019-09-03","2018-03-01",[1270],[3022],{"intervention":3045,"totalTrials":94,"cells":3046},"inhaled corticosteroids and other asthma drugs",{"EARLY_PHASE1":3047,"PHASE1":3049,"PHASE2":3051,"PHASE3":3053,"PHASE4":3055,"NA":3057},{"trials":3048,"activeCount":98},[],{"trials":3050,"activeCount":98},[],{"trials":3052,"activeCount":98},[],{"trials":3054,"activeCount":98},[],{"trials":3056,"activeCount":98},[],{"trials":3058,"activeCount":98},[3059],{"nctId":3060,"briefTitle":3061,"status":728,"phases":3062,"completion":3063,"start":3064,"enrollment":3065,"conditions":3066,"interventions":3067},"NCT00182481","LOMA: Long-Term Management of Asthma",[91],"2001-09","1999-09",112,[15],[3045],{"intervention":3069,"totalTrials":94,"cells":3070},"Bupivacaine",{"EARLY_PHASE1":3071,"PHASE1":3073,"PHASE2":3075,"PHASE3":3077,"PHASE4":3079,"NA":3081},{"trials":3072,"activeCount":98},[],{"trials":3074,"activeCount":98},[],{"trials":3076,"activeCount":98},[],{"trials":3078,"activeCount":98},[],{"trials":3080,"activeCount":98},[],{"trials":3082,"activeCount":98},[3083],{"nctId":3084,"briefTitle":3085,"status":728,"phases":3086,"primaryCompletion":3087,"completion":3088,"start":3089,"enrollment":3090,"conditions":3091,"interventions":3093},"NCT00887003","Epidural Study of Patients With Chronic Lower Back Pain",[91],"2011-08","2011-09","2005-05",252,[3092],"Chronic Low Back Pain",[3069,3069,3069,3069,3094],"Depo-Medrol",{"intervention":3094,"totalTrials":94,"cells":3096},{"EARLY_PHASE1":3097,"PHASE1":3099,"PHASE2":3101,"PHASE3":3103,"PHASE4":3105,"NA":3107},{"trials":3098,"activeCount":98},[],{"trials":3100,"activeCount":98},[],{"trials":3102,"activeCount":98},[],{"trials":3104,"activeCount":98},[],{"trials":3106,"activeCount":98},[],{"trials":3108,"activeCount":98},[3109],{"nctId":3084,"briefTitle":3085,"status":728,"phases":3110,"primaryCompletion":3087,"completion":3088,"start":3089,"enrollment":3090,"conditions":3111,"interventions":3112},[91],[3092],[3069,3069,3069,3069,3094]]